962 is the total number of securities SPHERA FUNDS MANAGEMENT LTD. has owned. The longest SPHERA FUNDS MANAGEMENT LTD. has owned a single stock is 36 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
TEVA | TEVA PHARMACEUTICAL-SP... | 17 | 2 | 0.08% | 2.17% | 8.41% | Q4 2013 | Q3 2023 | 36 |
MRK | MERCK & CO INC NEW | 21 | 2 | 1.50% | 4.20% | 8.36% | Q4 2013 | Q3 2023 | 35 |
NICE | NICE Systems Ltd | 8 | 1 | 0.03% | 1.06% | 4.42% | Q3 2014 | Q3 2023 | 27 |
BIIB | BIOGEN INC | 8 | 1 | 0.15% | 2.25% | 6.71% | Q4 2013 | Q3 2023 | 26 |
FOLD | AMICUS THERAPEUTICS INC | 20 | 1 | 0.39% | 1.69% | 4.29% | Q4 2014 | Q2 2022 | 26 |
PFE | PFIZER INC | 12 | 1 | 0.54% | 3.34% | 9.16% | Q4 2013 | Q3 2023 | 25 |
SRPT | SAREPTA THERAPEUTICS INC | 18 | 1 | 0.22% | 1.71% | 3.16% | Q4 2013 | Q3 2023 | 25 |
JNJ | JOHNSON & JOHNSON | 19 | 1 | 0.20% | 4.58% | 8.00% | Q4 2013 | Q3 2023 | 24 |
QURE | UNIQURE NV | 12 | 1 | 0.18% | 0.52% | 1.19% | Q1 2014 | Q3 2023 | 23 |
SNDX | SYNDAX PHARMACEUTICALS... | 15 | 7 | 0.09% | 1.39% | 3.88% | Q3 2016 | Q3 2023 | 22 |
ALDX | ALDEYRA THERAPEUTICS INC | 21 | 1 | 0.12% | 0.65% | 1.81% | Q1 2015 | Q2 2021 | 22 |
AZN | ASTRAZENECA PLC | 15 | 1 | 0.35% | 4.00% | 7.85% | Q1 2015 | Q3 2023 | 21 |
GILD | GILEAD SCIENCES INC | 8 | 1 | 0.48% | 2.57% | 6.90% | Q4 2013 | Q3 2023 | 21 |
PANW | PALO ALTO NETWORKS INC | 7 | 1 | 0.18% | 0.81% | 1.97% | Q3 2015 | Q3 2023 | 21 |
ASND | ASCENDIS PHARMA A/S | 19 | 1 | 0.13% | 0.76% | 1.67% | Q1 2015 | Q1 2022 | 21 |
ABBV | ABBVIE INC | 15 | 1 | 1.18% | 3.45% | 6.91% | Q3 2014 | Q3 2023 | 20 |
LLY | LILLY ELI & CO | 14 | 2 | 0.78% | 3.24% | 6.76% | Q1 2014 | Q3 2023 | 20 |
NVS | NOVARTIS AG-REG | 9 | 1 | 0.23% | 2.94% | 11.90% | Q4 2013 | Q3 2023 | 20 |
VTGN | VISTAGEN THERAPEUTICS INC | 13 | 7 | 0.07% | 0.41% | 0.88% | Q2 2016 | Q2 2022 | 20 |
MSFT | MICROSOFT CORP | 16 | 3 | 0.66% | 1.38% | 2.63% | Q1 2018 | Q3 2023 | 19 |
PTCT | PTC THERAPEUTICS INC | 9 | 1 | 0.01% | 0.70% | 1.62% | Q4 2013 | Q3 2023 | 19 |
SAGE | SAGE THERAPEUTICS INC | 14 | 1 | 0.04% | 0.62% | 1.20% | Q3 2014 | Q2 2023 | 19 |
SNY | SANOFI | 11 | 2 | 3.00% | 5.05% | 7.62% | Q1 2014 | Q3 2023 | 18 |
SHPG | SHIRE PLC | 17 | 1 | 0.24% | 2.36% | 5.61% | Q4 2013 | Q2 2018 | 18 |
ALXN | ALEXION PHARMACEUTICAL... | 10 | 1 | 0.45% | 2.06% | 6.04% | Q1 2015 | Q4 2020 | 18 |
CSTE | CAESARSTONE SDOT-YAM LTD | 8 | 2 | 0.04% | 0.74% | 2.68% | Q1 2014 | Q1 2022 | 18 |
RTRX | RETROPHIN INC | 8 | 1 | 0.28% | 0.72% | 1.46% | Q1 2015 | Q2 2020 | 18 |
MGNX | MACROGENICS INC | 17 | 1 | 0.20% | 0.46% | 0.91% | Q1 2014 | Q1 2019 | 18 |
CELG | CELGENE CORP | 13 | 4 | 0.84% | 3.42% | 6.08% | Q1 2015 | Q3 2019 | 17 |
BMY | BRISTOL-MYERS SQUIBB CO | 8 | 2 | 0.65% | 3.15% | 8.70% | Q4 2014 | Q1 2021 | 17 |
BMRN | BIOMARIN PHARMACEUTICA... | 7 | 1 | 0.06% | 1.15% | 2.30% | Q2 2014 | Q1 2022 | 17 |
ARRY | ARRAY BIOPHARMA INC | 10 | 7 | 0.13% | 0.72% | 2.00% | Q2 2014 | Q4 2018 | 17 |
IMMU | IMMUNOMEDICS INC | 12 | 2 | 0.10% | 0.68% | 1.67% | Q1 2014 | Q1 2019 | 17 |
ORBK | ORBOTECH LTD | 17 | 17 | 0.16% | 0.67% | 1.28% | Q4 2013 | Q4 2017 | 17 |
PIRS | PIERIS PHARMACEUTICALS... | 15 | 2 | 0.12% | 0.44% | 0.95% | Q2 2015 | Q1 2021 | 17 |
PRQR | PROQR THRAPEUTICS N V | 14 | 1 | 0.19% | 0.43% | 0.89% | Q3 2014 | Q1 2020 | 17 |
KURA | KURA ONCOLOGY INC | 14 | 2 | 0.82% | 1.20% | 1.56% | Q1 2018 | Q3 2023 | 16 |
KRNT | KORNIT DIGITAL LTD | 6 | 1 | 0.00% | 0.62% | 1.24% | Q1 2017 | Q3 2022 | 16 |
PTLA | PORTOLA PHARMACEUTICAL... | 6 | 1 | 0.19% | 0.56% | 1.20% | Q4 2013 | Q4 2019 | 16 |
SEDG | SOLAREDGE TECHNOLOGIES... | 4 | 1 | 0.08% | 0.55% | 1.48% | Q4 2016 | Q3 2022 | 16 |
GSK | GLAXOSMITHKLINE PLC-SP... | 9 | 1 | 0.55% | 3.18% | 8.18% | Q4 2013 | Q2 2019 | 15 |
VRNT | Verint Systems Inc | 6 | 1 | 0.46% | 1.27% | 3.18% | Q2 2014 | Q4 2021 | 15 |
AMZN | AMAZON COM INC | 12 | 3 | 0.04% | 1.09% | 2.53% | Q1 2019 | Q3 2023 | 15 |
CLVS | CLOVIS ONCOLOGY INC | 11 | 4 | 0.39% | 0.97% | 1.86% | Q4 2013 | Q1 2018 | 15 |
CNCE | CONCERT PHARMACEUTICAL... | 6 | 3 | 0.02% | 0.48% | 1.26% | Q3 2014 | Q4 2022 | 15 |
CYTK | CYTOKINETICS INC | 5 | 1 | 0.08% | 0.38% | 1.26% | Q4 2013 | Q3 2023 | 15 |
NICE SYS INC | 12 | 3 | 0.03% | 0.07% | 0.14% | Q3 2018 | Q4 2022 | 15 | |
MYL | MYLAN N V | 7 | 1 | 0.93% | 2.69% | 5.57% | Q1 2015 | Q4 2019 | 14 |
SWTX | SPRINGWORKS THERAPEUTI... | 12 | 2 | 0.20% | 1.39% | 3.67% | Q3 2019 | Q3 2023 | 14 |
FB | META PLATFORMS INC | 7 | 1 | 0.15% | 0.76% | 1.54% | Q4 2016 | Q3 2023 | 14 |
V | VISA INC | 12 | 2 | 0.26% | 0.75% | 1.12% | Q4 2015 | Q2 2022 | 14 |
ALLT | ALLOT LTD | 14 | 14 | 0.27% | 0.70% | 1.52% | Q3 2018 | Q4 2021 | 14 |
RCKT | ROCKET PHARMACEUTICALS... | 9 | 2 | 0.09% | 0.62% | 1.19% | Q1 2018 | Q3 2023 | 14 |
ARGX | ARGENX SE | 14 | 14 | 0.16% | 0.42% | 1.19% | Q3 2018 | Q4 2021 | 14 |
VRTX | VERTEX PHARMACEUTICALS... | 2 | 1 | 0.09% | 0.72% | 2.08% | Q1 2014 | Q4 2021 | 13 |
GLYC | GLYCOMIMETICS INC | 6 | 1 | 0.27% | 0.63% | 1.36% | Q1 2014 | Q1 2019 | 13 |
CRVS | CORVUS PHARMACEUTICALS... | 13 | 13 | 0.03% | 0.58% | 1.19% | Q1 2016 | Q1 2019 | 13 |
WIX | WIX COM LTD | 3 | 1 | 0.11% | 0.44% | 1.40% | Q4 2014 | Q3 2022 | 13 |
MRTX | MIRATI THERAPEUTICS INC | 5 | 2 | 0.10% | 0.38% | 0.77% | Q1 2015 | Q2 2021 | 13 |
MRNS | MARINUS PHARMACEUTICAL... | 12 | 1 | 0.04% | 0.36% | 0.67% | Q3 2014 | Q2 2019 | 13 |
AAP | ADVANCE AUTO PARTS INC | 6 | 2 | 0.04% | 0.36% | 1.16% | Q4 2015 | Q2 2019 | 13 |
SNA | SNAP ON INC | 9 | 4 | 0.03% | 0.30% | 0.52% | Q3 2014 | Q3 2018 | 13 |
IMTXW | IMMATICS N.V | 13 | 13 | 0.02% | 0.04% | 0.06% | Q3 2020 | Q3 2023 | 13 |
XBI | SPDR SER TR | 3 | 1 | 3.75% | 13.05% | 27.56% | Q3 2017 | Q3 2021 | 12 |
NVO | NOVO-NORDISK A S | 7 | 1 | 1.43% | 2.77% | 4.34% | Q1 2019 | Q3 2023 | 12 |
ITRN | Ituran Location and Co... | 7 | 1 | 0.52% | 1.43% | 2.71% | Q3 2014 | Q3 2019 | 12 |
RETA | REATA PHARMACEUTICALS INC | 9 | 1 | 0.12% | 0.84% | 1.46% | Q3 2017 | Q1 2023 | 12 |
ISEE | IVERIC BIO INC | 9 | 3 | 0.05% | 0.79% | 1.84% | Q4 2019 | Q2 2023 | 12 |
GOOGL | ALPHABET INC | 11 | 1 | 0.45% | 0.72% | 1.15% | Q1 2016 | Q1 2019 | 12 |
KZR | KEZAR LIFE SCIENCES INC | 8 | 1 | 0.05% | 0.68% | 1.97% | Q2 2018 | Q3 2023 | 12 |
NERV | MINERVA NEUROSCIENCES INC | 12 | 12 | 0.13% | 0.67% | 1.21% | Q2 2017 | Q1 2020 | 12 |
XENE | XENON PHARMACEUTICALS INC | 5 | 1 | 0.10% | 0.63% | 3.48% | Q3 2016 | Q3 2023 | 12 |
MLNX | MELLANOX TECHNOLOGIES LTD | 9 | 1 | 0.08% | 0.61% | 1.30% | Q4 2014 | Q4 2019 | 12 |
CHTR | CHARTER COMMUNICATIONS... | 10 | 2 | 0.05% | 0.54% | 1.18% | Q2 2016 | Q3 2019 | 12 |
TRILLIUM THERAPEUTICS INC | 7 | 5 | 0.20% | 0.47% | 0.90% | Q1 2015 | Q1 2021 | 12 | |
TJX | TJX COS INC NEW | 6 | 2 | 0.05% | 0.46% | 1.16% | Q4 2013 | Q4 2017 | 12 |
WAB | WABTEC CORP | 5 | 1 | 0.13% | 0.34% | 0.64% | Q1 2015 | Q4 2019 | 12 |
ITEK | INOTEK PHARMACEUTICALS... | 12 | 12 | 0.10% | 0.33% | 0.62% | Q1 2015 | Q4 2017 | 12 |
SMMT | SUMMIT THERAPEUTICS PLC | 12 | 12 | 0.22% | 0.31% | 0.41% | Q1 2015 | Q4 2017 | 12 |
PTN | PALATIN TECHNOLOGIES INC | 12 | 12 | 0.03% | 0.20% | 0.38% | Q3 2014 | Q2 2017 | 12 |
ELLO | ELLOMAY CAPITAL LTD | 12 | 12 | 0.01% | 0.17% | 0.34% | Q4 2013 | Q3 2016 | 12 |
SPDR S&P Biotech ETF | 4 | 1 | 0.83% | 6.92% | 17.27% | Q1 2014 | Q2 2018 | 11 | |
Teva Pharmaceutical In... | 7 | 2 | 0.31% | 1.87% | 4.35% | Q4 2013 | Q4 2022 | 11 | |
IMTX | IMMATICS N.V | 9 | 2 | 0.68% | 0.97% | 1.46% | Q3 2020 | Q3 2023 | 11 |
MRUS | MERUS N V | 11 | 11 | 0.12% | 0.91% | 1.53% | Q1 2021 | Q3 2023 | 11 |
BLUE | BLUEBIRD BIO INC | 5 | 1 | 0.24% | 0.84% | 1.57% | Q4 2013 | Q4 2019 | 11 |
ADMS | ADAMAS PHARMACEUTICALS... | 11 | 11 | 0.35% | 0.78% | 1.22% | Q4 2015 | Q2 2018 | 11 |
CLSD | CLEARSIDE BIOMEDICAL INC | 11 | 11 | 0.14% | 0.70% | 1.68% | Q2 2016 | Q4 2018 | 11 |
AUDC | AUDIOCODES LTD | 5 | 2 | 0.06% | 0.67% | 1.05% | Q2 2018 | Q3 2021 | 11 |
DCPH | DECIPHERA PHARMACEUTIC... | 7 | 4 | 0.12% | 0.63% | 1.73% | Q3 2017 | Q4 2020 | 11 |
KITE | KITE PHARMA INC | 11 | 11 | 0.24% | 0.51% | 1.09% | Q3 2014 | Q1 2017 | 11 |
GNCA | GENOCEA BIOSCIENCES INC | 11 | 11 | 0.10% | 0.47% | 0.77% | Q1 2015 | Q3 2017 | 11 |
NEOS | NEOS THERAPEUTICS INC | 11 | 11 | 0.06% | 0.42% | 0.89% | Q4 2017 | Q2 2020 | 11 |
MA | MASTERCARD INCORPORATED | 8 | 1 | 0.20% | 0.38% | 0.62% | Q3 2014 | Q1 2022 | 11 |
CATB | CATABASIS PHARMACEUTIC... | 11 | 11 | 0.06% | 0.22% | 0.50% | Q2 2015 | Q4 2017 | 11 |
AGN | ALLERGAN PLC | 6 | 4 | 1.15% | 3.59% | 6.14% | Q2 2015 | Q2 2018 | 10 |
TEVA | TEVA PHARMACEUTICAL IN... | 3 | 1 | 0.79% | 3.36% | 9.58% | Q2 2019 | Q3 2023 | 10 |
ORA | ORMAT TECHNOLOGIES INC | 9 | 1 | 0.06% | 1.40% | 5.67% | Q1 2014 | Q3 2016 | 10 |
CLLS | CELLECTIS S A | 9 | 1 | 0.18% | 1.04% | 1.62% | Q1 2015 | Q1 2019 | 10 |
SGEN | SEATTLE GENETICS INC | 4 | 2 | 0.25% | 0.91% | 2.81% | Q4 2013 | Q2 2017 | 10 |
ALNY | ALNYLAM PHARMACEUTICAL... | 4 | 1 | 0.40% | 0.90% | 2.65% | Q2 2015 | Q3 2023 | 10 |
ALT | ALTIMMUNE INC | 9 | 1 | 0.21% | 0.88% | 1.74% | Q3 2020 | Q2 2023 | 10 |
ACOR | ACORDA THERAPEUTICS INC | 6 | 1 | 0.13% | 0.66% | 1.25% | Q2 2014 | Q4 2017 | 10 |
VNDA | VANDA PHARMACEUTICALS INC | 10 | 10 | 0.24% | 0.58% | 0.93% | Q4 2013 | Q1 2016 | 10 |
ONCR | ONCORUS INC | 10 | 10 | 0.03% | 0.57% | 2.52% | Q4 2020 | Q1 2023 | 10 |
CAMT | CAMTEK LTD | 3 | 1 | 0.04% | 0.52% | 1.14% | Q2 2017 | Q2 2023 | 10 |
FWP | FORWARD PHARMA A/S | 10 | 10 | 0.34% | 0.49% | 0.71% | Q4 2014 | Q1 2017 | 10 |
STRO | SUTRO BIOPHARMA INC | 5 | 5 | 0.37% | 0.48% | 0.69% | Q3 2018 | Q4 2021 | 10 |
FPRX | FIVE PRIME THERAPEUTIC... | 8 | 1 | 0.23% | 0.48% | 0.88% | Q1 2014 | Q3 2017 | 10 |
HOWL | WEREWOLF THERAPEUTICS INC | 10 | 10 | 0.24% | 0.48% | 0.99% | Q2 2021 | Q3 2023 | 10 |
PRTA | PROTHENA CORP PLC | 5 | 2 | 0.08% | 0.42% | 0.90% | Q4 2013 | Q4 2017 | 10 |
ABEO | ABEONA THERAPEUTICS INC | 5 | 1 | 0.08% | 0.34% | 0.64% | Q3 2015 | Q4 2019 | 10 |
ALNA | ALLENA PHARMACEUTICALS... | 10 | 10 | 0.08% | 0.34% | 0.69% | Q4 2017 | Q1 2020 | 10 |
MHK | MOHAWK INDS INC | 8 | 2 | 0.03% | 0.13% | 0.52% | Q3 2016 | Q1 2019 | 10 |
CLRB | CELLECTAR BIOSCIENCES INC | 10 | 10 | 0.01% | 0.02% | 0.03% | Q3 2018 | Q4 2020 | 10 |
ISHARES TR | 5 | 1 | 0.05% | 4.68% | 16.96% | Q1 2014 | Q2 2018 | 9 | |
GNRC | GENERAC HLDGS INC | 8 | 1 | 0.05% | 1.77% | 2.93% | Q3 2020 | Q4 2022 | 9 |
CRNX | CRINETICS PHARMACEUTIC... | 9 | 9 | 0.22% | 1.20% | 2.64% | Q1 2021 | Q1 2023 | 9 |
ARQL | ARQULE INC | 8 | 1 | 0.17% | 1.15% | 2.68% | Q4 2013 | Q4 2019 | 9 |
RARE | ULTRAGENYX PHARMACEUTI... | 5 | 1 | 0.38% | 1.07% | 1.83% | Q2 2015 | Q3 2023 | 9 |
TSRO | TESARO INC | 4 | 2 | 0.24% | 0.83% | 1.47% | Q2 2015 | Q1 2018 | 9 |
EIGR | EIGER BIOPHARMACEUTICA... | 9 | 9 | 0.52% | 0.78% | 1.14% | Q1 2016 | Q1 2018 | 9 |
VKTX | VIKING THERAPEUTICS INC | 6 | 3 | 0.08% | 0.71% | 1.72% | Q3 2017 | Q2 2020 | 9 |
GWPH | GW PHARMACEUTICALS PLC | 4 | 1 | 0.24% | 0.67% | 1.32% | Q1 2015 | Q4 2019 | 9 |
ICPT | Intercept Pharmaceutic... | 5 | 2 | 0.27% | 0.57% | 1.26% | Q3 2014 | Q2 2019 | 9 |
SELB | SELECTA BIOSCIENCES INC | 6 | 3 | 0.14% | 0.57% | 1.17% | Q3 2016 | Q3 2023 | 9 |
KRYS | KRYSTAL BIOTECH INC | 5 | 1 | 0.24% | 0.53% | 0.78% | Q4 2018 | Q1 2022 | 9 |
CTMX | CYTOMX THERAPEUTICS INC | 9 | 9 | 0.18% | 0.46% | 0.78% | Q1 2017 | Q1 2019 | 9 |
FOMX | FOAMIX PHARMACEUTICALS... | 9 | 9 | 0.19% | 0.45% | 0.96% | Q1 2015 | Q1 2017 | 9 |
CPRX | CATALYST PHARM PARTNER... | 7 | 1 | 0.23% | 0.39% | 0.54% | Q3 2014 | Q2 2020 | 9 |
XLRN | ACCELERON PHARMA INC | 3 | 1 | 0.16% | 0.39% | 0.65% | Q4 2013 | Q2 2017 | 9 |
EDGE | EDGE THERAPEUTICS INC | 9 | 9 | 0.25% | 0.35% | 0.51% | Q4 2015 | Q4 2017 | 9 |
PMVP | PMV PHARMACEUTICALS INC | 5 | 4 | 0.11% | 0.28% | 0.48% | Q1 2021 | Q2 2023 | 9 |
DYN | DYNE THERAPEUTICS INC | 6 | 3 | 0.02% | 0.28% | 0.54% | Q3 2020 | Q2 2023 | 9 |
SPNS | SAPIENS INTL CORP N V | 6 | 1 | 0.05% | 0.27% | 0.66% | Q4 2013 | Q3 2017 | 9 |
OCRX | OCERA THERAPEUTICS INC | 6 | 3 | 0.05% | 0.22% | 0.46% | Q4 2013 | Q1 2016 | 9 |
ABUS | ARBUTUS BIOPHARMA CORP | 6 | 1 | 0.01% | 0.21% | 0.41% | Q3 2015 | Q3 2019 | 9 |
CYCC | CYCLACEL PHARMACEUTICA... | 5 | 4 | 0.02% | 0.14% | 0.28% | Q1 2021 | Q2 2023 | 9 |
MGIC | MAGIC SOFTWARE ENTERPR... | 7 | 2 | 0.02% | 0.12% | 0.23% | Q1 2019 | Q4 2022 | 9 |
UNH | UNITEDHEALTH GROUP INC | 9 | 9 | 0.04% | 0.06% | 0.07% | Q3 2016 | Q3 2018 | 9 |
AMGN | AMGEN INC | 3 | 1 | 0.40% | 1.63% | 2.75% | Q1 2015 | Q1 2023 | 8 |
VRX | VALEANT PHARMACEUTICAL... | 8 | 8 | 0.36% | 0.94% | 2.40% | Q3 2014 | Q2 2016 | 8 |
FATE | FATE THERAPEUTICS INC | 8 | 8 | 0.49% | 0.82% | 1.19% | Q2 2020 | Q1 2022 | 8 |
KDNY | CHINOOK THERAPEUTICS INC | 6 | 2 | 0.12% | 0.69% | 1.46% | Q4 2020 | Q1 2023 | 8 |
FGEN | FIBROGEN INC | 8 | 8 | 0.28% | 0.67% | 1.00% | Q2 2016 | Q1 2018 | 8 |
LJPC | LA JOLLA PHARMACEUTICA... | 6 | 2 | 0.22% | 0.61% | 1.18% | Q3 2014 | Q1 2018 | 8 |
STOK | STOKE THERAPEUTICS INC | 4 | 2 | 0.08% | 0.60% | 1.33% | Q2 2019 | Q4 2022 | 8 |
UNP | Union Pacific Corp | 5 | 3 | 0.20% | 0.56% | 0.95% | Q3 2014 | Q3 2017 | 8 |
TEVA PHARMACEUTICAL FI... | 8 | 8 | 0.09% | 0.54% | 1.47% | Q4 2016 | Q3 2018 | 8 | |
ZYME | ZYMEWORKS INC | 6 | 2 | 0.13% | 0.53% | 1.03% | Q2 2018 | Q4 2020 | 8 |
ARVN | ARVINAS INC | 7 | 1 | 0.27% | 0.52% | 0.74% | Q3 2018 | Q3 2020 | 8 |
RXDX | IGNYTA INC | 4 | 1 | 0.03% | 0.48% | 1.08% | Q1 2014 | Q4 2017 | 8 |
VRNA | VERONA PHARMA PLC | 7 | 1 | 0.17% | 0.47% | 0.64% | Q3 2020 | Q3 2022 | 8 |
SBUX | STARBUCKS CORP | 5 | 3 | 0.28% | 0.43% | 0.64% | Q4 2014 | Q1 2017 | 8 |
BLCM | BELLICUM PHARMACEUTICA... | 4 | 2 | 0.04% | 0.42% | 0.69% | Q1 2015 | Q4 2019 | 8 |
RLYP | RELYPSA INC | 5 | 1 | 0.21% | 0.41% | 0.67% | Q4 2013 | Q2 2016 | 8 |
ZFGN | ZAFGEN INC | 3 | 1 | 0.03% | 0.32% | 0.68% | Q3 2014 | Q1 2020 | 8 |
EVOK | EVOKE PHARMA INC | 8 | 8 | 0.12% | 0.31% | 0.49% | Q1 2017 | Q4 2018 | 8 |
IMDZ | IMMUNE DESIGN CORP | 8 | 8 | 0.14% | 0.30% | 0.45% | Q1 2015 | Q4 2016 | 8 |
ALPN | ALPINE IMMUNE SCIENCES... | 5 | 3 | 0.16% | 0.25% | 0.38% | Q3 2020 | Q3 2023 | 8 |
GNVC | GENVEC INC | 8 | 8 | 0.05% | 0.18% | 0.36% | Q1 2014 | Q4 2015 | 8 |
SERV | SERVICEMASTER GLOBAL H... | 7 | 1 | 0.03% | 0.08% | 0.29% | Q2 2016 | Q3 2018 | 8 |
OTLKW | OUTLOOK THERAPEUTICS INC | 8 | 8 | 0.00% | 0.01% | 0.02% | Q1 2020 | Q4 2021 | 8 |
KYMR | KYMERA THERAPEUTICS INC | 7 | 7 | 0.51% | 1.30% | 2.22% | Q3 2020 | Q1 2022 | 7 |
CCCC | C4 THERAPEUTICS INC | 7 | 7 | 0.57% | 1.24% | 1.43% | Q4 2020 | Q2 2022 | 7 |
CLCD | COLUCID PHARMACEUTICAL... | 7 | 7 | 0.16% | 1.14% | 3.30% | Q2 2015 | Q4 2016 | 7 |
PNT | POINT BIOPHARMA GLOBAL... | 5 | 2 | 0.36% | 1.02% | 1.49% | Q3 2021 | Q3 2023 | 7 |
INCY | Incyte Corp Ltd | 4 | 1 | 0.37% | 1.00% | 1.83% | Q4 2013 | Q4 2017 | 7 |
YMAB | Y-MABS THERAPEUTICS INC | 7 | 7 | 0.55% | 0.88% | 1.50% | Q2 2019 | Q4 2020 | 7 |
INZY | INOZYME PHARMA INC | 6 | 1 | 0.37% | 0.79% | 1.71% | Q3 2020 | Q3 2023 | 7 |
ACAD | ACADIA PHARMACEUTICALS... | 3 | 1 | 0.50% | 0.75% | 1.26% | Q4 2015 | Q1 2020 | 7 |
CLDX | CELLDEX THERAPEUTICS I... | 3 | 2 | 0.35% | 0.70% | 0.93% | Q3 2020 | Q3 2023 | 7 |
BURL | BURLINGTON STORES INC | 3 | 1 | 0.24% | 0.65% | 1.33% | Q3 2016 | Q4 2021 | 7 |
OBSV | OBSEVA SA | 7 | 7 | 0.30% | 0.60% | 1.53% | Q1 2017 | Q3 2018 | 7 |
KDMN | KADMON HLDGS INC | 7 | 7 | 0.35% | 0.58% | 0.96% | Q3 2017 | Q1 2019 | 7 |
BRCM | BROADCOM CORP-CL A | 7 | 7 | 0.13% | 0.58% | 0.81% | Q4 2013 | Q2 2015 | 7 |
FSCT | FORESCOUT TECHNOLOGIES... | 7 | 7 | 0.29% | 0.58% | 1.02% | Q2 2018 | Q4 2019 | 7 |
NBIX | NEUROCRINE BIOSCIENCES... | 4 | 1 | 0.19% | 0.56% | 1.27% | Q4 2014 | Q4 2017 | 7 |
FVRR | FIVERR INTL LTD | 6 | 1 | 0.28% | 0.54% | 1.16% | Q2 2019 | Q2 2021 | 7 |
AERI | AERIE PHARMACEUTICALS INC | 6 | 1 | 0.29% | 0.51% | 0.67% | Q4 2013 | Q1 2019 | 7 |
GBT | GLOBAL BLOOD THERAPEUT... | 3 | 1 | 0.16% | 0.49% | 0.70% | Q4 2016 | Q1 2020 | 7 |
EPZM | EPIZYME INC | 3 | 1 | 0.17% | 0.45% | 0.87% | Q2 2014 | Q4 2018 | 7 |
INSM | INSMED INC | 3 | 1 | 0.22% | 0.42% | 0.60% | Q4 2013 | Q3 2017 | 7 |
AGLE | AEGLEA BIOTHERAPEUTICS... | 5 | 2 | 0.03% | 0.42% | 0.74% | Q2 2018 | Q1 2023 | 7 |
TXMD | THERAPEUTICSMD INC | 4 | 3 | 0.23% | 0.41% | 0.82% | Q1 2015 | Q4 2017 | 7 |
NVMI | NOVA MEASURING INSTRUM... | 2 | 1 | 0.05% | 0.41% | 1.28% | Q1 2014 | Q2 2023 | 7 |
INBX | INHIBRX INC | 5 | 2 | 0.13% | 0.41% | 0.87% | Q4 2020 | Q3 2023 | 7 |
ETNB | 89BIO INC | 3 | 2 | 0.15% | 0.40% | 0.90% | Q3 2020 | Q3 2023 | 7 |
PRGO | PERRIGO CO PLC | 2 | 1 | 0.02% | 0.37% | 1.28% | Q1 2014 | Q2 2021 | 7 |
VINC | VINCERX PHARMA INC | 7 | 7 | 0.01% | 0.36% | 0.89% | Q4 2020 | Q2 2022 | 7 |
RIGL | RIGEL PHARMACEUTICALS INC | 6 | 1 | 0.18% | 0.35% | 0.73% | Q4 2013 | Q3 2023 | 7 |
KALV | KALVISTA PHARMACEUTICA... | 6 | 1 | 0.22% | 0.34% | 0.51% | Q4 2019 | Q4 2021 | 7 |
TRVN | TREVENA INC | 6 | 1 | 0.08% | 0.34% | 0.56% | Q1 2014 | Q1 2017 | 7 |
LPTX | LEAP THERAPEUTICS INC | 4 | 3 | 0.12% | 0.29% | 0.62% | Q1 2018 | Q4 2020 | 7 |
VTVT | VTV THERAPEUTICS INC | 7 | 7 | 0.17% | 0.25% | 0.38% | Q3 2016 | Q1 2018 | 7 |
AQXP | AQUINOX PHARMACEUTICAL... | 5 | 2 | 0.09% | 0.24% | 0.55% | Q1 2014 | Q2 2018 | 7 |
ERYP | ERYTECH PHARMA | 5 | 2 | 0.08% | 0.17% | 0.38% | Q4 2017 | Q3 2019 | 7 |
SEE | SEALED AIR CORP NEW | 6 | 1 | 0.03% | 0.12% | 0.66% | Q4 2013 | Q1 2018 | 7 |
OTONOMO TECHNOLOGIES LTD | 7 | 7 | 0.02% | 0.11% | 0.27% | Q3 2021 | Q1 2023 | 7 | |
SNSS | SUNESIS PHARMACEUTICAL... | 4 | 3 | 0.03% | 0.10% | 0.24% | Q4 2016 | Q1 2020 | 7 |
ARBE ROBOTICS LTD | 7 | 7 | 0.02% | 0.04% | 0.12% | Q4 2021 | Q2 2023 | 7 | |
LOW | LOWES COS INC | 6 | 1 | 0.03% | 0.04% | 0.05% | Q3 2016 | Q3 2018 | 7 |
ULTI | ULTIMATE SOFTWARE GROU... | 7 | 7 | 0.02% | 0.03% | 0.03% | Q1 2017 | Q3 2018 | 7 |
AMGEN INC | 5 | 1 | 0.23% | 1.63% | 3.36% | Q4 2013 | Q2 2016 | 6 | |
XLV | SELECT SECTOR SPDR TR | 6 | 6 | 0.39% | 1.01% | 2.13% | Q4 2013 | Q1 2015 | 6 |
UTHR | UNITED THERAPEUTICS CO... | 5 | 1 | 0.48% | 0.99% | 1.63% | Q1 2014 | Q3 2015 | 6 |
GILEAD SCIENCES INC | 4 | 2 | 0.26% | 0.93% | 2.55% | Q1 2014 | Q3 2016 | 6 | |
KROS | KEROS THERAPEUTICS INC | 6 | 6 | 0.20% | 0.83% | 1.64% | Q4 2021 | Q1 2023 | 6 |
IOVA | IOVANCE BIOTHERAPEUTIC... | 3 | 3 | 0.52% | 0.75% | 1.02% | Q2 2020 | Q4 2021 | 6 |
ALBO | ALBIREO PHARMA INC | 3 | 1 | 0.11% | 0.75% | 2.15% | Q2 2017 | Q4 2022 | 6 |
MDVN | MEDIVATION INC | 5 | 1 | 0.38% | 0.73% | 1.33% | Q4 2013 | Q2 2015 | 6 |
FISV | FISERV INC | 4 | 2 | 0.32% | 0.69% | 1.08% | Q1 2019 | Q3 2020 | 6 |
CHKP | CHECK POINT SOFTWARE T... | 4 | 2 | 0.41% | 0.69% | 1.00% | Q4 2013 | Q4 2015 | 6 |
TSEM | TOWER SEMICONDUCTOR LTD | 3 | 1 | 0.00% | 0.68% | 2.10% | Q1 2016 | Q3 2023 | 6 |
MYOK | MYOKARDIA INC | 2 | 2 | 0.22% | 0.66% | 1.08% | Q3 2016 | Q3 2020 | 6 |
NEURODERM LTD | 4 | 1 | 0.22% | 0.66% | 1.09% | Q3 2015 | Q2 2017 | 6 | |
EPIX | ESSA PHARMA INC | 6 | 6 | 0.17% | 0.64% | 1.25% | Q3 2020 | Q4 2021 | 6 |
FIVERR INTL LTD | 6 | 6 | 0.04% | 0.63% | 1.34% | Q4 2021 | Q1 2023 | 6 | |
AXGT | AXOVANT SCIENCES LTD | 6 | 6 | 0.17% | 0.60% | 0.90% | Q2 2019 | Q3 2020 | 6 |
AUTL | AUTOLUS THERAPEUTICS PLC | 5 | 1 | 0.20% | 0.60% | 1.03% | Q2 2018 | Q4 2022 | 6 |
PBYI | PUMA BIOTECHNOLOGY INC | 4 | 2 | 0.34% | 0.55% | 0.89% | Q2 2014 | Q1 2018 | 6 |
FIXX | HOMOLOGY MEDICINES INC | 5 | 1 | 0.38% | 0.53% | 0.94% | Q1 2018 | Q2 2020 | 6 |
RPTX | REPARE THERAPEUTICS INC | 6 | 6 | 0.21% | 0.53% | 0.74% | Q2 2020 | Q3 2021 | 6 |
ALDR | ALDER BIOPHARMACEUTICA... | 5 | 1 | 0.33% | 0.52% | 0.65% | Q1 2015 | Q3 2016 | 6 |
CARA | CARA THERAPEUTICS INC | 3 | 3 | 0.06% | 0.44% | 0.70% | Q2 2015 | Q1 2019 | 6 |
BOLD | AUDENTES THERAPEUTICS INC | 4 | 1 | 0.35% | 0.44% | 0.54% | Q3 2016 | Q3 2018 | 6 |
ARDX | ARDELYX INC | 6 | 6 | 0.27% | 0.43% | 0.85% | Q3 2016 | Q4 2017 | 6 |
ITCI | INTRA CELLULAR THERAPI... | 4 | 2 | 0.37% | 0.42% | 0.54% | Q1 2014 | Q4 2015 | 6 |
GRTX | GALERA THERAPEUTICS INC | 6 | 6 | 0.22% | 0.41% | 0.56% | Q4 2019 | Q1 2021 | 6 |
SBBP | STRONGBRIDGE BIOPHARMA... | 4 | 2 | 0.06% | 0.40% | 0.66% | Q4 2015 | Q1 2019 | 6 |
RZLT | REZOLUTE INC | 6 | 6 | 0.24% | 0.39% | 0.51% | Q2 2022 | Q3 2023 | 6 |
AXSM | AXSOME THERAPEUTICS INC | 4 | 2 | 0.20% | 0.31% | 0.47% | Q4 2015 | Q4 2017 | 6 |
IMVT | IMMUNOVANT INC | 6 | 6 | 0.03% | 0.30% | 0.70% | Q4 2019 | Q1 2021 | 6 |
RDWR | RADWARE LTD | 3 | 1 | 0.05% | 0.18% | 0.35% | Q4 2013 | Q2 2019 | 6 |
IWM | ISHARES TR | 3 | 1 | 1.63% | 6.90% | 12.88% | Q1 2020 | Q1 2023 | 5 |
SELECT SECTOR SPDR TR | 3 | 1 | 0.98% | 5.29% | 11.02% | Q3 2014 | Q1 2016 | 5 | |
SRPT | SAREPTA THERAPEUTICS INC | 2 | 1 | 0.97% | 2.51% | 5.60% | Q3 2017 | Q2 2023 | 5 |
XBI | SPDR SER TR | 2 | 1 | 0.36% | 1.28% | 3.48% | Q4 2018 | Q3 2023 | 5 |
BBIO | BRIDGEBIO PHARMA INC | 3 | 2 | 0.11% | 1.04% | 1.66% | Q4 2020 | Q3 2023 | 5 |
QURE | UNIQURE NV | 2 | 1 | 0.23% | 1.00% | 2.83% | Q1 2019 | Q1 2023 | 5 |
HZNP | HORIZON PHARMA PLC | 4 | 1 | 0.21% | 0.98% | 1.58% | Q3 2015 | Q1 2017 | 5 |
ENDP | ENDO INTL PLC | 2 | 1 | 0.46% | 0.80% | 1.96% | Q1 2015 | Q1 2018 | 5 |
ALXO | ALX ONCOLOGY HLDGS INC | 5 | 5 | 0.68% | 0.79% | 1.02% | Q3 2020 | Q3 2021 | 5 |
BCOMF | B COMMUNICATIONS LTD | 3 | 1 | 0.41% | 0.78% | 1.16% | Q2 2014 | Q2 2016 | 5 |
VSAR | VERSARTIS INC | 5 | 5 | 0.11% | 0.77% | 1.25% | Q3 2016 | Q3 2017 | 5 |
AMAG | AMAG PHARMACEUTICALS INC | 5 | 5 | 0.43% | 0.74% | 1.14% | Q3 2014 | Q3 2015 | 5 |
CSX | CSX CORP | 5 | 5 | 0.37% | 0.68% | 1.13% | Q4 2013 | Q4 2014 | 5 |
COGT | UNUM THERAPEUTICS INC | 3 | 2 | 0.51% | 0.66% | 0.78% | Q4 2020 | Q3 2023 | 5 |
DRNA | DICERNA PHARMACEUTICAL... | 2 | 1 | 0.35% | 0.64% | 1.25% | Q4 2014 | Q4 2020 | 5 |
P103PS | NPS PHARMACEUTICALS INC | 5 | 5 | 0.40% | 0.59% | 1.08% | Q4 2013 | Q4 2014 | 5 |
TW | TOWERS WATSON & CO | 5 | 5 | 0.16% | 0.58% | 1.07% | Q2 2014 | Q2 2015 | 5 |
BHVN | BIOHAVEN PHARMACTL HLD... | 5 | 5 | 0.41% | 0.58% | 0.75% | Q1 2018 | Q1 2019 | 5 |
XCUR | EXICURE INC | 5 | 5 | 0.13% | 0.58% | 1.03% | Q3 2019 | Q3 2020 | 5 |
DBVT | DBV TECHNOLOGIES S A | 5 | 5 | 0.47% | 0.57% | 0.70% | Q2 2016 | Q2 2017 | 5 |
GRCL | GRACELL BIOTECHNOLOGIE... | 3 | 2 | 0.21% | 0.54% | 0.80% | Q1 2021 | Q3 2023 | 5 |
PTGX | PROTAGONIST THERAPEUTI... | 3 | 2 | 0.37% | 0.51% | 0.92% | Q4 2019 | Q3 2021 | 5 |
BLSA | BCLS ACQUISITION CORP | 5 | 5 | 0.23% | 0.49% | 0.61% | Q4 2020 | Q4 2021 | 5 |
CVS | CVS HEALTH CORP | 5 | 5 | 0.36% | 0.48% | 0.61% | Q1 2014 | Q1 2015 | 5 |
XFOR | X4 PHARMACEUTICALS INC | 5 | 5 | 0.09% | 0.48% | 1.09% | Q2 2019 | Q2 2020 | 5 |
MLNT | MELINTA THERAPEUTICS INC | 5 | 5 | 0.14% | 0.48% | 0.86% | Q4 2017 | Q4 2018 | 5 |
ORTX | ORCHARD THERAPEUTICS PLC | 3 | 2 | 0.21% | 0.47% | 0.76% | Q4 2018 | Q2 2021 | 5 |
KERX | KERYX BIOPHARMACEUTICA... | 2 | 1 | 0.27% | 0.47% | 0.97% | Q4 2014 | Q3 2016 | 5 |
EGLTQ | EGALET CORP | 5 | 5 | 0.36% | 0.44% | 0.55% | Q3 2015 | Q3 2016 | 5 |
CYNA | CYNAPSUS THERAPEUTICS INC | 5 | 5 | 0.30% | 0.43% | 0.58% | Q2 2015 | Q2 2016 | 5 |
DTIL | PRECISION BIOSCIENCES INC | 5 | 5 | 0.11% | 0.42% | 0.61% | Q1 2019 | Q1 2020 | 5 |
RCPT | RECEPTOS INC | 5 | 5 | 0.19% | 0.42% | 0.63% | Q2 2014 | Q2 2015 | 5 |
STML | STEMLINE THERAPEUTICS INC | 4 | 1 | 0.12% | 0.42% | 0.55% | Q1 2015 | Q4 2017 | 5 |
IONS | IONIS PHARMACEUTICALS INC | 2 | 1 | 0.06% | 0.42% | 0.74% | Q4 2015 | Q3 2021 | 5 |
MDCO | Medicines Co/The | 3 | 1 | 0.29% | 0.41% | 0.50% | Q4 2013 | Q4 2015 | 5 |
KMPH | KEMPHARM INC | 4 | 1 | 0.02% | 0.41% | 0.58% | Q2 2015 | Q2 2018 | 5 |
HRTX | HERON THERAPEUTICS INC | 3 | 1 | 0.12% | 0.39% | 0.73% | Q1 2015 | Q1 2017 | 5 |
SVRA | SAVARA INC | 3 | 2 | 0.09% | 0.39% | 0.70% | Q2 2017 | Q4 2018 | 5 |
CBAY | CYMABAY THERAPEUTICS INC | 3 | 1 | 0.11% | 0.37% | 0.65% | Q3 2014 | Q1 2019 | 5 |
ONTY | ONCOTHYREON INC | 5 | 5 | 0.10% | 0.34% | 0.59% | Q4 2013 | Q4 2014 | 5 |
ORLY | O REILLY AUTOMOTIVE IN... | 5 | 5 | 0.05% | 0.33% | 0.43% | Q3 2017 | Q3 2018 | 5 |
RPRX | REPROS THERAPEUTICS INC | 3 | 1 | 0.17% | 0.32% | 0.61% | Q4 2013 | Q1 2017 | 5 |
AGIO | AGIOS PHARMACEUTICALS INC | 2 | 1 | 0.00% | 0.31% | 0.48% | Q2 2014 | Q4 2018 | 5 |
ARYAU | ARYA SCIENCES ACQUISIT... | 5 | 5 | 0.19% | 0.30% | 0.38% | Q2 2019 | Q2 2020 | 5 |
DK | DELEK US HLDGS INC NEW | 3 | 2 | 0.05% | 0.27% | 0.76% | Q1 2018 | Q3 2019 | 5 |
NVLS | NIVALIS THERAPEUTICS INC | 4 | 1 | 0.07% | 0.26% | 0.38% | Q2 2015 | Q3 2016 | 5 |
GILT | GILAT SATELLITE NETWOR... | 5 | 5 | 0.14% | 0.26% | 0.64% | Q1 2018 | Q1 2019 | 5 |
SRRA | SIERRA ONCOLOGY INC | 5 | 5 | 0.04% | 0.25% | 0.44% | Q4 2017 | Q4 2018 | 5 |
SCYX | SCYNEXIS INC | 5 | 5 | 0.07% | 0.24% | 0.29% | Q2 2015 | Q2 2016 | 5 |
KBIO | KALOBIOS PHARMACEUTICA... | 5 | 5 | 0.07% | 0.21% | 0.47% | Q4 2013 | Q4 2014 | 5 |
SBPH | SPRING BK PHARMACEUTIC... | 3 | 2 | 0.05% | 0.20% | 0.40% | Q2 2017 | Q1 2019 | 5 |
INFI | INFINITY PHARMACEUTICA... | 4 | 1 | 0.04% | 0.18% | 0.38% | Q4 2013 | Q2 2023 | 5 |
MRSN | MERSANA THERAPEUTICS INC | 3 | 2 | 0.01% | 0.10% | 0.22% | Q1 2019 | Q2 2023 | 5 |
CMG | CHIPOTLE MEXICAN GRILL... | 4 | 1 | 0.01% | 0.09% | 0.36% | Q4 2013 | Q4 2017 | 5 |
SITE | SITEONE LANDSCAPE SUPP... | 3 | 2 | 0.03% | 0.04% | 0.08% | Q3 2016 | Q3 2018 | 5 |
CUE | CUE BIOPHARMA INC | 5 | 5 | 0.02% | 0.04% | 0.06% | Q3 2018 | Q3 2019 | 5 |
SPDR S&P 500 ETF TR | 2 | 1 | 4.65% | 7.53% | 11.94% | Q1 2015 | Q1 2017 | 4 | |
QQQ | INVESCO QQQ TR | 2 | 1 | 3.67% | 5.78% | 7.27% | Q2 2020 | Q2 2023 | 4 |
ISHARES TR | 3 | 1 | 1.07% | 4.27% | 9.43% | Q1 2015 | Q3 2016 | 4 | |
XLF | SELECT SECTOR SPDR TR | 2 | 1 | 0.51% | 2.38% | 4.64% | Q4 2013 | Q4 2017 | 4 |
ESLT | Elbit Systems Ltd | 2 | 1 | 0.70% | 1.76% | 3.72% | Q3 2014 | Q1 2016 | 4 |
CELJF | CELLCOM ISRAEL LTD | 2 | 2 | 0.75% | 1.39% | 2.04% | Q3 2015 | Q4 2017 | 4 |
FIVN | FIVE9 INC | 3 | 1 | 0.46% | 1.13% | 1.38% | Q4 2021 | Q4 2022 | 4 |
RLMD | RELMADA THERAPEUTICS INC | 4 | 4 | 0.95% | 1.06% | 1.18% | Q4 2021 | Q3 2022 | 4 |
AKAOQ | ACHAOGEN INC | 4 | 4 | 0.28% | 0.99% | 1.70% | Q3 2016 | Q2 2017 | 4 |
ZLAB | ZAI LAB LTD | 4 | 4 | 0.67% | 0.98% | 1.29% | Q1 2021 | Q4 2021 | 4 |
ASTRIA THERAPEUTICS INC | 4 | 4 | 0.61% | 0.96% | 1.50% | Q4 2022 | Q3 2023 | 4 | |
ARCELLX INC | 4 | 4 | 0.38% | 0.92% | 1.58% | Q3 2022 | Q2 2023 | 4 | |
PRAX | PRAXIS PRECISION MEDIC... | 2 | 1 | 0.09% | 0.92% | 1.57% | Q4 2020 | Q3 2023 | 4 |
DYAX | DYAX CORP | 4 | 4 | 0.64% | 0.90% | 1.54% | Q2 2014 | Q1 2015 | 4 |
PERION NETWORK LTD | 2 | 1 | 0.60% | 0.88% | 1.08% | Q4 2021 | Q1 2023 | 4 | |
CL | COLGATE-PALMOLIVE CO | 4 | 4 | 0.32% | 0.76% | 0.97% | Q4 2013 | Q3 2014 | 4 |
WIX COM LTD | 2 | 2 | 0.06% | 0.74% | 1.91% | Q3 2021 | Q3 2022 | 4 | |
VRNS | VARONIS SYS INC | 4 | 4 | 0.55% | 0.72% | 0.85% | Q3 2020 | Q2 2021 | 4 |
ARYD | ARYA SCIENCES ACQU COR... | 4 | 4 | 0.36% | 0.67% | 1.09% | Q1 2021 | Q4 2021 | 4 |
S | SENTINELONE INC | 2 | 1 | 0.20% | 0.66% | 1.11% | Q2 2021 | Q3 2022 | 4 |
BLU | BELLUS HEALTH INC NEW | 3 | 1 | 0.10% | 0.65% | 0.96% | Q2 2020 | Q1 2023 | 4 |
RDUS | RADIUS HEALTH INC | 3 | 1 | 0.39% | 0.62% | 0.86% | Q3 2014 | Q2 2016 | 4 |
WVE | WAVE LIFE SCIENCES LTD | 3 | 1 | 0.29% | 0.61% | 1.10% | Q2 2019 | Q4 2020 | 4 |
GOOGL | GOOGLE INC-CL A | 3 | 1 | 0.28% | 0.60% | 0.84% | Q1 2014 | Q4 2015 | 4 |
AVEO | AVEO PHARMACEUTICALS INC | 4 | 4 | 0.33% | 0.58% | 0.83% | Q1 2017 | Q4 2017 | 4 |
HARP | HARPOON THERAPEUTICS INC | 4 | 4 | 0.29% | 0.55% | 0.79% | Q1 2019 | Q4 2019 | 4 |
IDYA | IDEAYA BIOSCIENCES INC | 4 | 4 | 0.36% | 0.52% | 0.63% | Q1 2021 | Q4 2021 | 4 |
IMAB | I MAB | 4 | 4 | 0.20% | 0.52% | 0.84% | Q3 2020 | Q2 2021 | 4 |
AFMD | AFFIMED NV | 3 | 1 | 0.12% | 0.51% | 0.73% | Q3 2014 | Q3 2021 | 4 |
PCLN | PRICELINE GRP INC | 3 | 1 | 0.22% | 0.51% | 0.64% | Q4 2013 | Q1 2015 | 4 |
IMUX | IMMUNIC INC | 3 | 1 | 0.11% | 0.51% | 0.93% | Q2 2020 | Q1 2022 | 4 |
GLAXOSMITHKLINE PLC-SP... | 4 | 4 | 0.00% | 0.51% | 1.65% | Q1 2014 | Q4 2014 | 4 | |
NAUT | NAUTILUS BIOTECHNOLOGY... | 4 | 4 | 0.41% | 0.48% | 0.55% | Q2 2021 | Q1 2022 | 4 |
PRTK | PARATEK PHARMACEUTICAL... | 4 | 4 | 0.30% | 0.47% | 0.55% | Q2 2016 | Q1 2017 | 4 |
AGTC | Applied Genetic Techno... | 4 | 4 | 0.30% | 0.47% | 0.59% | Q3 2014 | Q2 2015 | 4 |
RUN | SUNRUN INC | 2 | 1 | 0.25% | 0.47% | 0.70% | Q2 2021 | Q3 2022 | 4 |
FLEX | FLEX LTD | 3 | 1 | 0.24% | 0.44% | 0.76% | Q2 2017 | Q3 2018 | 4 |
ADRO | ADURO BIOTECH INC | 4 | 4 | 0.28% | 0.44% | 0.50% | Q4 2015 | Q3 2016 | 4 |
ICL | ISRAEL CHEMICALS LTD | 2 | 2 | 0.04% | 0.43% | 1.23% | Q3 2014 | Q1 2016 | 4 |
CTIC | CTI BIOPHARMA CORP | 4 | 4 | 0.26% | 0.43% | 0.60% | Q3 2017 | Q2 2018 | 4 |
RPTP | RAPTOR PHARMACEUTICAL ... | 4 | 4 | 0.32% | 0.42% | 0.52% | Q2 2015 | Q1 2016 | 4 |
ADMA | ADMA BIOLOGICS INC | 4 | 4 | 0.18% | 0.41% | 0.66% | Q4 2019 | Q3 2020 | 4 |
SGMO | SANGAMO THERAPEUTICS INC | 2 | 1 | 0.23% | 0.40% | 0.52% | Q4 2014 | Q2 2019 | 4 |
CASC | CASCADIAN THERAPEUTICS... | 4 | 4 | 0.30% | 0.40% | 0.47% | Q1 2017 | Q4 2017 | 4 |
LRCX | LAM RESEARCH CORP | 3 | 1 | 0.35% | 0.38% | 0.41% | Q2 2017 | Q2 2018 | 4 |
CTSH | COGNIZANT TECHNOLOGY S... | 2 | 1 | 0.32% | 0.37% | 0.46% | Q4 2015 | Q4 2017 | 4 |
ANAB | ANAPTYSBIO INC | 2 | 1 | 0.14% | 0.35% | 0.47% | Q1 2017 | Q1 2019 | 4 |
BCAB | BIOATLA INC | 2 | 1 | 0.15% | 0.35% | 0.53% | Q4 2020 | Q4 2022 | 4 |
MDGN | MEDGENICS INC | 2 | 2 | 0.15% | 0.35% | 0.65% | Q4 2014 | Q3 2016 | 4 |
RACA | THERAPEUTICS ACQUISITI... | 4 | 4 | 0.02% | 0.33% | 0.70% | Q3 2020 | Q2 2021 | 4 |
DVAX | DYNAVAX TECHNOLOGIES CORP | 3 | 1 | 0.31% | 0.32% | 0.34% | Q2 2015 | Q3 2021 | 4 |
OUTBRAIN INC | 3 | 1 | 0.01% | 0.32% | 0.66% | Q3 2021 | Q4 2022 | 4 | |
TTPH | Tetraphase Pharmaceuti... | 2 | 2 | 0.01% | 0.30% | 0.66% | Q2 2014 | Q2 2015 | 4 |
TLOG | TetraLogic Pharmaceuti... | 4 | 4 | 0.10% | 0.29% | 0.46% | Q4 2013 | Q3 2014 | 4 |
ORGS | ORGENESIS INC | 4 | 4 | 0.01% | 0.28% | 0.53% | Q1 2020 | Q4 2020 | 4 |
DOVA | DOVA PHARMACEUTICALS INC | 2 | 2 | 0.16% | 0.27% | 0.36% | Q2 2017 | Q4 2018 | 4 |
ACIU | AC IMMUNE SA | 2 | 1 | 0.07% | 0.27% | 0.46% | Q3 2016 | Q3 2021 | 4 |
CHTR | CHARTER COMMUNICATIONS... | 4 | 4 | 0.09% | 0.27% | 0.70% | Q2 2015 | Q1 2016 | 4 |
EXEL | EXELIXIS INC | 4 | 4 | 0.13% | 0.25% | 0.37% | Q1 2015 | Q4 2015 | 4 |
ASMB | ASSEMBLY BIOSCIENCES INC | 2 | 1 | 0.14% | 0.22% | 0.43% | Q1 2015 | Q4 2019 | 4 |
AOS | SMITH A O | 4 | 4 | 0.03% | 0.22% | 0.42% | Q1 2015 | Q4 2015 | 4 |
DSCO | DISCOVERY LABORATORIES... | 4 | 4 | 0.11% | 0.22% | 0.31% | Q4 2013 | Q3 2014 | 4 |
MEDIWOUND LTD | 4 | 4 | 0.18% | 0.22% | 0.25% | Q4 2022 | Q3 2023 | 4 | |
ACHN | Achillion Pharmaceutic... | 2 | 1 | 0.07% | 0.20% | 0.28% | Q2 2014 | Q3 2017 | 4 |
TBRA | TOBIRA THERAPEUTICS INC | 4 | 4 | 0.06% | 0.18% | 0.28% | Q2 2015 | Q1 2016 | 4 |
ANNX | ANNEXON INC | 3 | 1 | 0.16% | 0.18% | 0.23% | Q2 2021 | Q1 2023 | 4 |
BLRX | BIOLINERX LTD-SPONS ADR | 3 | 1 | 0.04% | 0.17% | 0.31% | Q1 2014 | Q1 2015 | 4 |
CMCSA | COMCAST CORP NEW | 3 | 1 | 0.02% | 0.16% | 0.36% | Q3 2017 | Q3 2018 | 4 |
YMTX | YUMANITY THERAPEUTICS INC | 4 | 4 | 0.07% | 0.16% | 0.29% | Q4 2020 | Q3 2021 | 4 |
LVTX | LAVA THERAPEUTICS NV | 4 | 4 | 0.08% | 0.15% | 0.25% | Q1 2021 | Q4 2021 | 4 |
WSO | WATSCO INC | 4 | 4 | 0.04% | 0.05% | 0.06% | Q2 2017 | Q1 2018 | 4 |
TRIP | TRIPADVISOR INC | 4 | 4 | 0.02% | 0.02% | 0.03% | Q1 2017 | Q4 2017 | 4 |
XRAY | DENTSPLY SIRONA INC | 4 | 4 | 0.02% | 0.02% | 0.03% | Q2 2017 | Q1 2018 | 4 |
BNTC | BENITEC BIOPHARMA LTD | 4 | 4 | 0.00% | 0.02% | 0.03% | Q3 2018 | Q2 2019 | 4 |
VSTO | VISTA OUTDOOR INC | 4 | 4 | 0.01% | 0.02% | 0.02% | Q2 2017 | Q1 2018 | 4 |
ATHX | ATHERSYS INC | 3 | 1 | 0.00% | 0.00% | 0.00% | Q1 2017 | Q1 2018 | 4 |
INVESCO QQQ TR | 2 | 1 | 8.91% | 10.99% | 12.08% | Q3 2022 | Q3 2023 | 3 | |
SPY | SPDR S&P 500 ETF TR | 2 | 1 | 5.13% | 5.79% | 6.77% | Q1 2020 | Q1 2023 | 3 |
B108PS | ACTAVIS PLC | 3 | 3 | 3.64% | 4.76% | 5.95% | Q3 2014 | Q1 2015 | 3 |
ENPHASE ENERGY INC | 3 | 3 | 1.87% | 2.38% | 3.16% | Q1 2023 | Q3 2023 | 3 | |
ENPH | ENPHASE ENERGY INC | 2 | 1 | 1.05% | 2.25% | 2.86% | Q1 2021 | Q2 2023 | 3 |
MYLAN N V | 2 | 1 | 0.99% | 1.64% | 2.38% | Q3 2015 | Q2 2017 | 3 | |
IWM | ISHARES TR | 2 | 1 | 0.73% | 1.33% | 2.16% | Q4 2013 | Q1 2015 | 3 |
URGN | UROGEN PHARMA LTD | 3 | 3 | 1.04% | 1.26% | 1.52% | Q1 2019 | Q3 2019 | 3 |
SGTX | SIGILON THERAPEUTICS INC | 3 | 3 | 0.26% | 1.06% | 2.31% | Q4 2020 | Q2 2021 | 3 |
MDGL | MADRIGAL PHARMACEUTICA... | 3 | 3 | 0.77% | 1.01% | 1.35% | Q1 2023 | Q3 2023 | 3 |
DISC MEDICINE INC | 3 | 3 | 0.78% | 0.97% | 1.18% | Q1 2023 | Q3 2023 | 3 | |
JASPER THERAPEUTICS INC | 3 | 3 | 0.72% | 0.95% | 1.22% | Q1 2023 | Q3 2023 | 3 | |
ASPX | AUSPEX PHARMACEUTICALS... | 3 | 3 | 0.52% | 0.94% | 1.31% | Q3 2014 | Q1 2015 | 3 |
MINERALYS THERAPEUTICS... | 3 | 3 | 0.79% | 0.92% | 1.08% | Q1 2023 | Q3 2023 | 3 | |
PCYC | PHARMACYCLICS INC | 3 | 3 | 0.56% | 0.90% | 1.11% | Q2 2014 | Q4 2014 | 3 |
AMD | ADVANCED MICRO DEVICES... | 2 | 1 | 0.13% | 0.86% | 1.54% | Q1 2022 | Q3 2023 | 3 |
KPTI | KARYOPHARM THERAPEUTIC... | 3 | 3 | 0.52% | 0.85% | 1.32% | Q4 2019 | Q2 2020 | 3 |
Apple Inc | 2 | 1 | 0.62% | 0.83% | 0.99% | Q4 2013 | Q4 2014 | 3 | |
WAG | WALGREEN CO | 3 | 3 | 0.56% | 0.82% | 1.11% | Q4 2013 | Q2 2014 | 3 |
FUSN | FUSION PHARMACEUTICALS... | 3 | 3 | 0.64% | 0.81% | 0.97% | Q1 2023 | Q3 2023 | 3 |
KNSA | KINIKSA PHARMACEUTICAL... | 2 | 1 | 0.39% | 0.73% | 0.99% | Q3 2020 | Q1 2023 | 3 |
CERE | CEREVEL THERAPEUTICS H... | 3 | 3 | 0.02% | 0.72% | 1.19% | Q4 2020 | Q2 2021 | 3 |
PASG | PASSAGE BIO INC | 3 | 3 | 0.34% | 0.71% | 0.89% | Q1 2020 | Q3 2020 | 3 |
ZNTL | ZENTALIS PHARMACEUTICA... | 3 | 3 | 0.58% | 0.70% | 0.88% | Q3 2020 | Q1 2021 | 3 |
LPSN | LIVEPERSON INC | 2 | 1 | 0.00% | 0.67% | 1.05% | Q1 2018 | Q2 2021 | 3 |
BPMC | BLUEPRINT MEDICINES CORP | 3 | 3 | 0.48% | 0.66% | 0.80% | Q3 2019 | Q1 2020 | 3 |
NKE | NIKE INC -CL B | 2 | 1 | 0.33% | 0.65% | 0.84% | Q4 2013 | Q3 2021 | 3 |
SRRK | SCHOLAR ROCK HLDG CORP | 3 | 3 | 0.45% | 0.65% | 0.88% | Q2 2018 | Q4 2018 | 3 |
AVXS | AVEXIS INC | 3 | 3 | 0.54% | 0.63% | 0.67% | Q3 2016 | Q1 2017 | 3 |
ABNB | AIRBNB INC | 3 | 3 | 0.26% | 0.62% | 0.87% | Q4 2021 | Q2 2022 | 3 |
AXGT | AXOVANT SCIENCES LTD | 2 | 1 | 0.31% | 0.62% | 0.92% | Q4 2016 | Q1 2019 | 3 |
APD | AIR PRODS & CHEMS INC | 2 | 1 | 0.46% | 0.58% | 0.77% | Q1 2016 | Q4 2016 | 3 |
IRWD | IRONWOOD PHARMACEUTICA... | 2 | 1 | 0.31% | 0.58% | 1.12% | Q4 2013 | Q3 2014 | 3 |
DEPO | DEPOMED INC | 3 | 3 | 0.38% | 0.57% | 0.87% | Q1 2015 | Q3 2015 | 3 |
GRPH | GRAPHITE BIO INC | 3 | 3 | 0.05% | 0.56% | 0.91% | Q2 2021 | Q4 2021 | 3 |
NOMD | NOMAD FOODS LTD | 3 | 3 | 0.35% | 0.55% | 0.68% | Q2 2017 | Q4 2017 | 3 |
SBTX | SILVERBACK THERAPEUTIC... | 3 | 3 | 0.36% | 0.55% | 0.72% | Q4 2020 | Q2 2021 | 3 |
SLB | SCHLUMBERGER LTD | 2 | 1 | 0.36% | 0.54% | 0.73% | Q3 2014 | Q1 2017 | 3 |
FEZ | SPDR INDEX SHS FDS | 2 | 1 | 0.38% | 0.52% | 0.81% | Q1 2014 | Q2 2015 | 3 |
AVRO | AVROBIO INC | 2 | 1 | 0.28% | 0.50% | 0.81% | Q3 2019 | Q4 2020 | 3 |
ALDER BIOPHARMACEUTICA... | 2 | 1 | 0.24% | 0.49% | 0.73% | Q3 2014 | Q2 2016 | 3 | |
DERM | DERMIRA INC | 3 | 3 | 0.38% | 0.48% | 0.54% | Q1 2016 | Q3 2016 | 3 |
ITCI | INTRA CELLULAR THERAPI... | 2 | 1 | 0.33% | 0.47% | 0.55% | Q1 2019 | Q2 2020 | 3 |
AMBI | AMBIT BIOSCIENCES CORP | 3 | 3 | 0.31% | 0.47% | 0.63% | Q4 2013 | Q2 2014 | 3 |
RACB | RESEARCH ALLIANCE CORP II | 3 | 3 | 0.41% | 0.46% | 0.50% | Q1 2021 | Q3 2021 | 3 |
SRCL | STERICYCLE INC | 2 | 1 | 0.21% | 0.46% | 0.91% | Q4 2013 | Q1 2015 | 3 |
NTLA | INTELLIA THERAPEUTICS INC | 2 | 1 | 0.27% | 0.45% | 0.58% | Q1 2018 | Q3 2021 | 3 |
PTNR | PARTNER COMMUNICATIONS... | 3 | 3 | 0.31% | 0.44% | 0.63% | Q3 2015 | Q1 2016 | 3 |
CLDN | CELLADON CORP | 3 | 3 | 0.24% | 0.44% | 0.59% | Q2 2014 | Q4 2014 | 3 |
TKMR | TEKMIRA PHARMACEUTICAL... | 3 | 3 | 0.30% | 0.43% | 0.54% | Q4 2014 | Q2 2015 | 3 |
CYTR | CYTRX CORP | 3 | 3 | 0.32% | 0.43% | 0.54% | Q4 2013 | Q2 2014 | 3 |
ARPO | AERPIO PHARMACEUTICALS... | 3 | 3 | 0.22% | 0.42% | 0.63% | Q2 2018 | Q4 2018 | 3 |
ARYA | ARYA SCIENCES ACQUISIT... | 3 | 3 | 0.38% | 0.41% | 0.42% | Q3 2020 | Q1 2021 | 3 |
CMTA | CLEMENTIA PHARMACEUTIC... | 3 | 3 | 0.36% | 0.41% | 0.46% | Q3 2017 | Q1 2018 | 3 |
RGNX | REGENXBIO INC | 2 | 1 | 0.09% | 0.40% | 0.67% | Q4 2017 | Q2 2019 | 3 |
PTC THERAPEUTICS INC | 3 | 3 | 0.28% | 0.40% | 0.54% | Q1 2015 | Q3 2015 | 3 | |
ARWR | ARROWHEAD RESH CORP | 3 | 3 | 0.33% | 0.39% | 0.44% | Q2 2015 | Q4 2015 | 3 |
AEGR | AEGERION PHARMACEUTICA... | 2 | 1 | 0.26% | 0.39% | 0.57% | Q4 2014 | Q3 2015 | 3 |
ZGNX | ZOGENIX INC | 1 | 1 | 0.21% | 0.38% | 0.72% | Q3 2015 | Q3 2017 | 3 |
BITI | BIOTIE THERAPIES OYJ | 3 | 3 | 0.33% | 0.37% | 0.40% | Q2 2015 | Q4 2015 | 3 |
STTK | SHATTUCK LABS INC | 3 | 3 | 0.26% | 0.37% | 0.54% | Q4 2020 | Q2 2021 | 3 |
GLMD | GALMED PHARMACEUTICALS... | 2 | 1 | 0.25% | 0.37% | 0.44% | Q1 2014 | Q4 2017 | 3 |
LRMR | LARIMAR THERAPEUTICS INC | 2 | 1 | 0.11% | 0.37% | 0.51% | Q2 2020 | Q1 2021 | 3 |
OVID | OVID THERAPEUTICS INC | 3 | 3 | 0.21% | 0.37% | 0.52% | Q2 2017 | Q4 2017 | 3 |
NRIX | NURIX THERAPEUTICS INC | 2 | 1 | 0.08% | 0.34% | 0.51% | Q3 2020 | Q2 2021 | 3 |
ARKO | ARKO CORP | 3 | 3 | 0.23% | 0.34% | 0.48% | Q4 2020 | Q2 2021 | 3 |
TKAI | TOKAI PHARMACEUTICALS INC | 3 | 3 | 0.17% | 0.33% | 0.43% | Q3 2014 | Q1 2015 | 3 |
ISIS | ISIS PHARMACEUTICALS INC | 2 | 1 | 0.27% | 0.32% | 0.35% | Q4 2013 | Q3 2015 | 3 |
APLS | APELLIS PHARMACEUTICAL... | 3 | 3 | 0.17% | 0.31% | 0.43% | Q2 2018 | Q4 2018 | 3 |
AKBA | AKEBIA THERAPEUTICS INC | 2 | 1 | 0.20% | 0.31% | 0.50% | Q2 2014 | Q2 2020 | 3 |
HALO | HALOZYME THERAPEUTICS INC | 3 | 3 | 0.26% | 0.31% | 0.34% | Q2 2015 | Q4 2015 | 3 |
ARROWHEAD RESH CORP | 1 | 1 | 0.06% | 0.31% | 0.50% | Q4 2013 | Q4 2014 | 3 | |
LOGC | LOGICBIO THERAPEUTICS INC | 2 | 1 | 0.01% | 0.29% | 0.49% | Q4 2018 | Q3 2021 | 3 |
RNA | PROSENSA HOLDING BV | 2 | 1 | 0.23% | 0.29% | 0.39% | Q4 2013 | Q3 2014 | 3 |
VFC | V F CORP | 2 | 1 | 0.12% | 0.28% | 0.39% | Q3 2014 | Q2 2015 | 3 |
OTIC | OTONOMY INC | 2 | 1 | 0.25% | 0.28% | 0.33% | Q3 2014 | Q2 2015 | 3 |
TBIO | TRANSLATE BIO INC | 3 | 3 | 0.23% | 0.27% | 0.32% | Q2 2018 | Q4 2018 | 3 |
TMO | THERMO FISHER SCIENTIF... | 3 | 3 | 0.21% | 0.26% | 0.35% | Q4 2016 | Q2 2017 | 3 |
ACHL | ACHILLES THERAPEUTICS PLC | 3 | 3 | 0.16% | 0.24% | 0.38% | Q1 2021 | Q3 2021 | 3 |
CGEN | COMPUGEN LTD | 2 | 1 | 0.22% | 0.24% | 0.28% | Q2 2020 | Q3 2023 | 3 |
EUCR | EUCRATES BIOMEDICAL AC... | 3 | 3 | 0.22% | 0.24% | 0.27% | Q1 2021 | Q3 2021 | 3 |
LIFE | ATYR PHARMA INC | 3 | 3 | 0.05% | 0.23% | 0.36% | Q2 2015 | Q4 2015 | 3 |
3106PS | DELPHI AUTOMOTIVE PLC | 3 | 3 | 0.09% | 0.22% | 0.44% | Q2 2015 | Q4 2015 | 3 |
CBYL | CARBYLAN THERAPEUTICS INC | 3 | 3 | 0.18% | 0.22% | 0.28% | Q2 2015 | Q4 2015 | 3 |
VRCA | VERRICA PHARMACEUTICAL... | 3 | 3 | 0.09% | 0.22% | 0.34% | Q2 2018 | Q4 2018 | 3 |
ALRN | AILERON THERAPEUTICS INC | 3 | 3 | 0.16% | 0.21% | 0.24% | Q2 2017 | Q4 2017 | 3 |
NVAX | NOVAVAX INC | 2 | 1 | 0.00% | 0.21% | 0.49% | Q4 2014 | Q4 2015 | 3 |
MANNKIND CORP | 3 | 3 | 0.16% | 0.19% | 0.22% | Q3 2014 | Q1 2015 | 3 | |
SMMF | Summit Corp PLC | 3 | 3 | 0.01% | 0.17% | 0.40% | Q1 2014 | Q3 2014 | 3 |
CYT | CYTEIR THERAPEUTICS INC | 3 | 3 | 0.12% | 0.17% | 0.20% | Q2 2021 | Q4 2021 | 3 |
ONS | ONCOBIOLOGICS INC | 3 | 3 | 0.13% | 0.17% | 0.23% | Q2 2016 | Q4 2016 | 3 |
TMPM | TURMERIC ACQUISITION CORP | 3 | 3 | 0.15% | 0.16% | 0.18% | Q1 2021 | Q3 2021 | 3 |
RDCM | RADCOM LTD | 3 | 3 | 0.14% | 0.16% | 0.18% | Q4 2017 | Q2 2018 | 3 |
CNAT | CONATUS PHARMACEUTICAL... | 2 | 1 | 0.15% | 0.16% | 0.16% | Q4 2013 | Q1 2015 | 3 |
JYAC | JIYA ACQUISITION CORP | 3 | 3 | 0.13% | 0.15% | 0.16% | Q1 2021 | Q3 2021 | 3 |
ELEV | ELEVATION ONCOLOGY INC | 2 | 1 | 0.03% | 0.12% | 0.21% | Q2 2021 | Q3 2023 | 3 |
SAGE | SAGE THERAPEUTICS INC | 2 | 1 | 0.02% | 0.11% | 0.26% | Q3 2017 | Q4 2018 | 3 |
HSAQ | HEALTH SCIENCES ACQ CO... | 3 | 3 | 0.09% | 0.10% | 0.11% | Q3 2020 | Q1 2021 | 3 |
CEREW | CEREVEL THERAPEUTICS H... | 3 | 3 | 0.05% | 0.10% | 0.16% | Q4 2020 | Q2 2021 | 3 |
FLAC | FRAZIER LIFESCIENCES A... | 3 | 3 | 0.08% | 0.10% | 0.10% | Q1 2021 | Q3 2021 | 3 |
EARS | AURIS MEDICAL AG | 2 | 1 | 0.03% | 0.09% | 0.14% | Q3 2014 | Q2 2015 | 3 |
NBSE | NEUBASE THERAPEUTICS INC | 2 | 1 | 0.02% | 0.08% | 0.12% | Q2 2020 | Q1 2021 | 3 |
OMEG | OMEGA ALPHA SPAC | 3 | 3 | 0.07% | 0.08% | 0.08% | Q1 2021 | Q3 2021 | 3 |
ECL | ECOLAB INC | 3 | 3 | 0.02% | 0.03% | 0.04% | Q2 2017 | Q4 2017 | 3 |
LVNTA | LIBERTY INTERACTIVE CORP | 3 | 3 | 0.02% | 0.02% | 0.03% | Q2 2017 | Q4 2017 | 3 |
SRSA | SARISSA CAPITAL ACQUIS... | 3 | 3 | 0.02% | 0.02% | 0.02% | Q1 2021 | Q3 2021 | 3 |
LMNS | LUMENIS LTD | 2 | 1 | 0.00% | 0.00% | 0.00% | Q2 2014 | Q2 2015 | 3 |
IBB | ISHARES TR | 1 | 1 | 6.26% | 8.10% | 9.93% | Q4 2017 | Q4 2019 | 2 |
FIVN | FIVE9 INC | 2 | 2 | 2.70% | 3.29% | 3.88% | Q4 2021 | Q1 2022 | 2 |
PFIZER INC | 2 | 2 | 0.02% | 2.79% | 5.56% | Q4 2013 | Q1 2014 | 2 | |
ISRL | Isramco Negev 2 LP | 2 | 2 | 1.90% | 2.32% | 2.74% | Q3 2014 | Q4 2014 | 2 |
IGV | ISHARES TR | 2 | 2 | 1.86% | 2.31% | 2.77% | Q1 2021 | Q2 2021 | 2 |
Allergan Inc/United St... | 2 | 2 | 1.67% | 2.25% | 2.84% | Q2 2014 | Q3 2014 | 2 | |
XBI | SPDR SER TR | 1 | 1 | 1.59% | 2.15% | 2.71% | Q4 2021 | Q2 2022 | 2 |
CELGENE CORP | 2 | 2 | 1.15% | 2.03% | 2.91% | Q1 2017 | Q2 2017 | 2 | |
NICE | NICE LTD | 2 | 2 | 0.48% | 1.87% | 3.25% | Q2 2023 | Q3 2023 | 2 |
SLXP | SALIX PHARMACEUTICALS LTD | 2 | 2 | 0.39% | 1.74% | 3.10% | Q3 2014 | Q4 2014 | 2 |
REGN | REGENERON PHARMACEUTICALS | 1 | 1 | 1.28% | 1.73% | 2.17% | Q1 2018 | Q2 2019 | 2 |
ABBV | ABBVIE INC | 2 | 2 | 1.08% | 1.61% | 2.14% | Q3 2020 | Q4 2020 | 2 |
SRPT | SAREPTA THERAPEUTICS INC | 2 | 2 | 1.14% | 1.60% | 2.07% | Q3 2020 | Q4 2020 | 2 |
MNKKQ | MALLINCKRODT PLC | 2 | 2 | 1.51% | 1.52% | 1.53% | Q3 2014 | Q4 2014 | 2 |
FVRR | FIVERR INTL LTD | 2 | 2 | 1.30% | 1.48% | 1.67% | Q1 2021 | Q2 2021 | 2 |
INNT | INNOVATE BIOPHARMACEUT... | 2 | 2 | 1.08% | 1.47% | 1.86% | Q1 2018 | Q2 2018 | 2 |
BIOMARIN PHARMACEUTICA... | 1 | 1 | 1.20% | 1.27% | 1.34% | Q2 2015 | Q3 2016 | 2 | |
SHL TELEMEDICINE LTD | 2 | 2 | 1.24% | 1.26% | 1.27% | Q2 2023 | Q3 2023 | 2 | |
BIIB | BIOGEN INC | 2 | 2 | 1.17% | 1.18% | 1.19% | Q2 2021 | Q3 2021 | 2 |
Allergan Inc/United St... | 1 | 1 | 0.93% | 1.17% | 1.40% | Q4 2013 | Q4 2014 | 2 | |
DAWN | DAY ONE BIOPHARMACEUTI... | 2 | 2 | 0.99% | 1.09% | 1.18% | Q2 2023 | Q3 2023 | 2 |
ASTRAZENECA PLC-SPONS ADR | 2 | 2 | 1.04% | 1.05% | 1.06% | Q3 2014 | Q4 2014 | 2 | |
XLI | SELECT SECTOR SPDR TR | 2 | 2 | 0.65% | 1.01% | 1.38% | Q4 2013 | Q1 2014 | 2 |
GCVRZ | SANOFI | 2 | 2 | 0.95% | 1.00% | 1.06% | Q3 2014 | Q4 2014 | 2 |
CINCOR PHARMA INC | 2 | 2 | 0.54% | 0.97% | 1.40% | Q3 2022 | Q4 2022 | 2 | |
ENLIGHT RENEWABLE ENER... | 2 | 2 | 0.59% | 0.93% | 1.28% | Q1 2023 | Q2 2023 | 2 | |
RUN | SUNRUN INC | 2 | 2 | 0.86% | 0.92% | 0.98% | Q4 2021 | Q1 2022 | 2 |
Valeant Pharmaceutical... | 2 | 2 | 0.24% | 0.91% | 1.58% | Q3 2014 | Q4 2014 | 2 | |
AVNR | AVANIR PHARMACEUTICALS... | 2 | 2 | 0.37% | 0.88% | 1.39% | Q2 2014 | Q3 2014 | 2 |
PRGO | PERRIGO CO PLC | 1 | 1 | 0.65% | 0.88% | 1.10% | Q3 2015 | Q1 2021 | 2 |
TWLO | TWILIO INC | 2 | 2 | 0.71% | 0.83% | 0.95% | Q2 2021 | Q3 2021 | 2 |
QQQ | INVESCO QQQ TR | 1 | 1 | 0.24% | 0.83% | 1.41% | Q2 2022 | Q1 2023 | 2 |
PCP | PRECISION CASTPARTS CORP | 2 | 2 | 0.72% | 0.76% | 0.79% | Q4 2013 | Q1 2014 | 2 |
IONS | IONIS PHARMACEUTICALS INC | 2 | 2 | 0.50% | 0.74% | 0.99% | Q2 2021 | Q3 2021 | 2 |
YUM | Yum! Brands Inc | 2 | 2 | 0.36% | 0.74% | 1.13% | Q2 2014 | Q3 2014 | 2 |
MYL | Mylan Inc/PA | 2 | 2 | 0.55% | 0.74% | 0.93% | Q3 2014 | Q4 2014 | 2 |
FIS | FIDELITY NATL INFORMAT... | 2 | 2 | 0.60% | 0.72% | 0.83% | Q3 2016 | Q4 2016 | 2 |
XHB | SPDR SERIES TRUST | 2 | 2 | 0.38% | 0.67% | 0.95% | Q1 2019 | Q2 2019 | 2 |
COST | COSTCO WHSL CORP NEW | 2 | 2 | 0.39% | 0.66% | 0.92% | Q4 2013 | Q1 2014 | 2 |
PTGX | PROTAGONIST THERAPEUTI... | 2 | 2 | 0.37% | 0.66% | 0.94% | Q3 2021 | Q4 2021 | 2 |
OMEGA THERAPEUTICS INC | 2 | 2 | 0.44% | 0.64% | 0.84% | Q3 2021 | Q4 2021 | 2 | |
BTAI | BIOXCEL THERAPEUTICS INC | 2 | 2 | 0.12% | 0.63% | 1.15% | Q3 2020 | Q4 2020 | 2 |
GW PHARMACEUTICALS PLC | 1 | 1 | 0.51% | 0.62% | 0.74% | Q4 2015 | Q2 2016 | 2 | |
LESL | LESLIES INC | 2 | 2 | 0.26% | 0.61% | 0.97% | Q3 2021 | Q4 2021 | 2 |
TVTX | TRAVERE THERAPEUTICS INC | 2 | 2 | 0.51% | 0.61% | 0.70% | Q1 2023 | Q2 2023 | 2 |
GSK PLC | 2 | 2 | 0.56% | 0.61% | 0.66% | Q2 2023 | Q3 2023 | 2 | |
CHMA | CHIASMA INC | 1 | 1 | 0.46% | 0.61% | 0.76% | Q1 2016 | Q3 2019 | 2 |
Amgen Inc | 1 | 1 | 0.28% | 0.60% | 0.93% | Q2 2014 | Q4 2014 | 2 | |
FROG | JFROG LTD | 2 | 2 | 0.40% | 0.60% | 0.79% | Q3 2020 | Q4 2020 | 2 |
DPZ | DOMINOS PIZZA INC | 2 | 2 | 0.50% | 0.59% | 0.68% | Q2 2020 | Q3 2020 | 2 |
MORF | MORPHIC HLDG INC | 2 | 2 | 0.38% | 0.59% | 0.81% | Q2 2023 | Q3 2023 | 2 |
IFF | INTERNATIONAL FLAVORS&... | 1 | 1 | 0.58% | 0.59% | 0.60% | Q3 2018 | Q2 2019 | 2 |
TLT | ISHARES TR | 2 | 2 | 0.35% | 0.58% | 0.82% | Q1 2019 | Q2 2019 | 2 |
ONTO | ONTO INNOVATION INC | 2 | 2 | 0.53% | 0.58% | 0.63% | Q1 2021 | Q2 2021 | 2 |
SALIX PHARMACEUTICALS LTD | 2 | 2 | 0.22% | 0.58% | 0.94% | Q2 2014 | Q3 2014 | 2 | |
CSCO | CISCO SYS INC | 2 | 2 | 0.56% | 0.58% | 0.59% | Q2 2018 | Q3 2018 | 2 |
SCHW | SCHWAB CHARLES CORP NEW | 2 | 2 | 0.43% | 0.57% | 0.71% | Q4 2013 | Q1 2014 | 2 |
MIRM | MIRUM PHARMACEUTICALS INC | 1 | 1 | 0.44% | 0.55% | 0.66% | Q1 2023 | Q3 2023 | 2 |
OSMT | OSMOTICA PHARMACEUTICA... | 2 | 2 | 0.28% | 0.54% | 0.81% | Q4 2018 | Q1 2019 | 2 |
CRIS | CURIS INC | 2 | 2 | 0.32% | 0.54% | 0.77% | Q1 2021 | Q2 2021 | 2 |
REPL | REPLIMUNE GROUP INC | 1 | 1 | 0.51% | 0.54% | 0.58% | Q1 2022 | Q3 2023 | 2 |
LVS | LAS VEGAS SANDS CORP | 2 | 2 | 0.51% | 0.53% | 0.54% | Q4 2013 | Q1 2014 | 2 |
BGNE | BEIGENE LTD | 2 | 2 | 0.48% | 0.52% | 0.56% | Q1 2021 | Q2 2021 | 2 |
ADVANCE AUTO PARTS INC | 2 | 2 | 0.48% | 0.52% | 0.56% | Q1 2017 | Q2 2017 | 2 | |
AMYLYX PHARMACEUTICALS... | 2 | 2 | 0.34% | 0.49% | 0.65% | Q2 2023 | Q3 2023 | 2 | |
ONCE | SPARK THERAPEUTICS INC | 1 | 1 | 0.37% | 0.49% | 0.60% | Q3 2015 | Q4 2017 | 2 |
AMPE | Ampio Pharmaceuticals Inc | 2 | 2 | 0.33% | 0.48% | 0.64% | Q1 2014 | Q2 2014 | 2 |
GOOG | Google Inc | 2 | 2 | 0.32% | 0.48% | 0.64% | Q2 2014 | Q3 2014 | 2 |
HORIZON PHARMA PLC | 1 | 1 | 0.07% | 0.48% | 0.88% | Q3 2015 | Q4 2016 | 2 | |
NLTX | NEOLEUKIN THERAPEUTICS... | 2 | 2 | 0.39% | 0.48% | 0.56% | Q4 2019 | Q1 2020 | 2 |
SILC | SILICOM LTD | 2 | 2 | 0.46% | 0.47% | 0.48% | Q4 2013 | Q1 2014 | 2 |
ITB | ISHARES | 1 | 1 | 0.22% | 0.46% | 0.71% | Q4 2013 | Q1 2015 | 2 |
MYL | MYLAN N V | 2 | 2 | 0.25% | 0.46% | 0.67% | Q3 2017 | Q4 2017 | 2 |
BBIO | BRIDGEBIO PHARMA INC | 2 | 2 | 0.35% | 0.45% | 0.55% | Q1 2023 | Q2 2023 | 2 |
HON | HONEYWELL INTL INC | 1 | 1 | 0.39% | 0.43% | 0.48% | Q4 2015 | Q4 2017 | 2 |
ARYBU | ARYA SCIENCES ACQUISTI... | 2 | 2 | 0.33% | 0.43% | 0.54% | Q2 2020 | Q3 2020 | 2 |
ORIC | ORIC PHARMACEUTICALS INC | 2 | 2 | 0.32% | 0.43% | 0.55% | Q4 2020 | Q1 2021 | 2 |
EWG | ISHARES | 2 | 2 | 0.34% | 0.43% | 0.53% | Q1 2015 | Q2 2015 | 2 |
NVDA | NVIDIA CORPORATION | 2 | 2 | 0.18% | 0.43% | 0.67% | Q2 2022 | Q3 2022 | 2 |
BEAM | BEAM THERAPEUTICS INC | 1 | 1 | 0.25% | 0.42% | 0.60% | Q1 2020 | Q2 2021 | 2 |
FLKS | FLEX PHARMA INC | 2 | 2 | 0.33% | 0.42% | 0.51% | Q3 2017 | Q4 2017 | 2 |
AAPL | APPLE INC | 2 | 2 | 0.28% | 0.42% | 0.55% | Q1 2015 | Q2 2015 | 2 |
PTI | PROTEOSTASIS THERAPEUT... | 2 | 2 | 0.36% | 0.42% | 0.48% | Q4 2019 | Q1 2020 | 2 |
ASNS | ARSANIS INC | 2 | 2 | 0.40% | 0.40% | 0.40% | Q4 2017 | Q1 2018 | 2 |
NKTX | NKARTA INC | 2 | 2 | 0.26% | 0.40% | 0.54% | Q1 2021 | Q2 2021 | 2 |
SESN | SESEN BIO INC | 2 | 2 | 0.16% | 0.40% | 0.64% | Q2 2018 | Q3 2018 | 2 |
ATNM | ACTINIUM PHARMACEUTICA... | 2 | 2 | 0.24% | 0.39% | 0.53% | Q2 2014 | Q3 2014 | 2 |
MDLZ | MONDELEZ INTL INC | 2 | 2 | 0.32% | 0.38% | 0.45% | Q3 2015 | Q4 2015 | 2 |
IS | IRONSOURCE LTD | 1 | 1 | 0.34% | 0.38% | 0.42% | Q3 2021 | Q1 2022 | 2 |
VBIV | VBI VACCINES INC | 2 | 2 | 0.35% | 0.38% | 0.40% | Q4 2017 | Q1 2018 | 2 |
GNMX | AEVI GENOMIC MEDICINE INC | 2 | 2 | 0.15% | 0.37% | 0.59% | Q4 2016 | Q1 2017 | 2 |
ORCL | ORACLE CORP | 2 | 2 | 0.33% | 0.36% | 0.40% | Q2 2017 | Q3 2017 | 2 |
KMDA | KAMADA LTD | 2 | 2 | 0.19% | 0.36% | 0.54% | Q4 2014 | Q1 2015 | 2 |
RNN | REXAHN PHARMACEUTICALS... | 2 | 2 | 0.21% | 0.35% | 0.50% | Q4 2013 | Q1 2014 | 2 |
SNSS | SUNESIS PHARMACEUTICAL... | 2 | 2 | 0.33% | 0.35% | 0.36% | Q1 2015 | Q2 2015 | 2 |
CEMP | CEMPRA INC | 1 | 1 | 0.27% | 0.33% | 0.40% | Q4 2014 | Q3 2015 | 2 |
DICE THERAPEUTICS INC | 1 | 1 | 0.23% | 0.33% | 0.43% | Q3 2021 | Q3 2022 | 2 | |
INSYQ | INSYS THERAPEUTICS INC... | 1 | 1 | 0.06% | 0.33% | 0.60% | Q1 2015 | Q2 2016 | 2 |
OMED | ONCOMED PHARMACEUTICAL... | 2 | 2 | 0.23% | 0.33% | 0.43% | Q2 2014 | Q3 2014 | 2 |
ANAC | ANACOR PHARMACEUTICALS... | 2 | 2 | 0.15% | 0.32% | 0.50% | Q3 2015 | Q4 2015 | 2 |
XNCR | XENCOR INC | 2 | 2 | 0.27% | 0.32% | 0.38% | Q4 2013 | Q1 2014 | 2 |
EXPE | EXPEDIA INC DEL | 2 | 2 | 0.32% | 0.32% | 0.32% | Q4 2017 | Q1 2018 | 2 |
Teva Pharmaceutical In... | 1 | 1 | 0.02% | 0.32% | 0.61% | Q2 2014 | Q2 2017 | 2 | |
GLTO | GALECTO INC | 2 | 2 | 0.21% | 0.31% | 0.41% | Q4 2020 | Q1 2021 | 2 |
TBT | PROSHARES TR | 2 | 2 | 0.19% | 0.31% | 0.43% | Q4 2016 | Q1 2017 | 2 |
ICL | ICL GROUP LTD | 1 | 1 | 0.13% | 0.30% | 0.48% | Q3 2022 | Q3 2023 | 2 |
Vertex Pharmaceuticals... | 2 | 2 | 0.12% | 0.30% | 0.47% | Q1 2014 | Q2 2014 | 2 | |
PLRX | PLIANT THERAPEUTICS INC | 1 | 1 | 0.10% | 0.30% | 0.49% | Q2 2021 | Q3 2023 | 2 |
PAY | VERIFONE SYS INC | 2 | 2 | 0.27% | 0.29% | 0.31% | Q1 2015 | Q2 2015 | 2 |
MEDICINES CO | 2 | 2 | 0.28% | 0.29% | 0.29% | Q1 2015 | Q2 2015 | 2 | |
QLTI | QLT INC | 2 | 2 | 0.25% | 0.28% | 0.31% | Q4 2013 | Q1 2014 | 2 |
CYTK | CYTOKINETICS INC | 1 | 1 | 0.21% | 0.28% | 0.35% | Q3 2017 | Q3 2023 | 2 |
IPXL | IMPAX LABORATORIES INC | 2 | 2 | 0.07% | 0.28% | 0.49% | Q1 2015 | Q2 2015 | 2 |
CHRS | COHERUS BIOSCIENCES INC | 1 | 1 | 0.09% | 0.27% | 0.45% | Q1 2018 | Q1 2019 | 2 |
AAP | ADVANCE AUTO PARTS INC | 2 | 2 | 0.25% | 0.27% | 0.30% | Q3 2017 | Q4 2017 | 2 |
ENTA | ENANTA PHARMACEUTICALS... | 1 | 1 | 0.19% | 0.27% | 0.35% | Q4 2013 | Q4 2014 | 2 |
VERA | VERA THERAPEUTICS INC | 2 | 2 | 0.26% | 0.26% | 0.26% | Q2 2023 | Q3 2023 | 2 |
DPRX | Dipexium Pharmaceutica... | 2 | 2 | 0.23% | 0.26% | 0.29% | Q1 2014 | Q2 2014 | 2 |
ISHARES TR | 2 | 2 | 0.24% | 0.26% | 0.27% | Q1 2017 | Q2 2017 | 2 | |
ALGS | ALIGOS THERAPEUTICS INC | 1 | 1 | 0.18% | 0.25% | 0.32% | Q4 2020 | Q3 2021 | 2 |
BCLI | BRAINSTORM CELL THERAP... | 1 | 1 | 0.03% | 0.25% | 0.47% | Q3 2014 | Q2 2017 | 2 |
IMGN | IMMUNOGEN INC | 1 | 1 | 0.12% | 0.25% | 0.38% | Q1 2014 | Q4 2017 | 2 |
CVRX | CVRX INC | 2 | 2 | 0.21% | 0.25% | 0.28% | Q2 2021 | Q3 2021 | 2 |
RARX | RA PHARMACEUTICALS INC | 2 | 2 | 0.23% | 0.24% | 0.25% | Q4 2016 | Q1 2017 | 2 |
TEVA | TEVA PHARMACEUTICAL IN... | 1 | 1 | 0.18% | 0.23% | 0.28% | Q3 2017 | Q1 2022 | 2 |
TGTX | TG Therapeutics Inc | 2 | 2 | 0.14% | 0.23% | 0.32% | Q1 2014 | Q2 2014 | 2 |
APTX | APTINYX INC | 1 | 1 | 0.11% | 0.23% | 0.34% | Q2 2018 | Q1 2020 | 2 |
ZYNE | ZYNERBA PHARMACEUTICAL... | 1 | 1 | 0.05% | 0.22% | 0.39% | Q1 2017 | Q1 2020 | 2 |
EOLS | EVOLUS INC | 2 | 2 | 0.15% | 0.22% | 0.29% | Q4 2019 | Q1 2020 | 2 |
HCCCU | HEALTHCARE CAPITAL CORP | 2 | 2 | 0.13% | 0.22% | 0.30% | Q1 2021 | Q2 2021 | 2 |
NBRV | NABRIVA THERAPEUTICS AG | 2 | 2 | 0.21% | 0.22% | 0.22% | Q3 2015 | Q4 2015 | 2 |
MTEM | MOLECULAR TEMPLATES INC | 2 | 2 | 0.18% | 0.22% | 0.25% | Q3 2018 | Q4 2018 | 2 |
ARYA | ARYA SCIENCES ACQUISIT... | 2 | 2 | 0.19% | 0.21% | 0.23% | Q4 2018 | Q1 2019 | 2 |
IFRX | INFLARX NV | 1 | 1 | 0.11% | 0.20% | 0.30% | Q4 2019 | Q1 2021 | 2 |
PRVL | PREVAIL THERAPEUTICS INC | 2 | 2 | 0.17% | 0.20% | 0.24% | Q2 2019 | Q3 2019 | 2 |
IMVTU | IMMUNOVANT INC | 2 | 2 | 0.20% | 0.20% | 0.20% | Q4 2019 | Q1 2020 | 2 |
UROV | UROVANT SCIENCES LTD | 2 | 2 | 0.16% | 0.19% | 0.23% | Q3 2018 | Q4 2018 | 2 |
TJX Cos Inc | 2 | 2 | 0.02% | 0.19% | 0.37% | Q2 2014 | Q3 2014 | 2 | |
ARYA SCIENCES ACQUISIT... | 2 | 2 | 0.17% | 0.19% | 0.21% | Q3 2021 | Q4 2021 | 2 | |
GLUE | MONTE ROSA THERAPEUTIC... | 2 | 2 | 0.15% | 0.19% | 0.22% | Q2 2021 | Q3 2021 | 2 |
AYLA | AYALA PHARMACEUTICALS INC | 2 | 2 | 0.14% | 0.19% | 0.23% | Q4 2021 | Q1 2022 | 2 |
ATHA | ATHIRA PHARMA INC | 2 | 2 | 0.16% | 0.18% | 0.20% | Q3 2020 | Q4 2020 | 2 |
AXTA | AXALTA COATING SYS LTD | 2 | 2 | 0.13% | 0.18% | 0.22% | Q3 2015 | Q4 2015 | 2 |
AMAT | APPLIED MATLS INC | 1 | 1 | 0.16% | 0.17% | 0.18% | Q3 2021 | Q4 2022 | 2 |
EWTX | EDGEWISE THERAPEUTICS INC | 1 | 1 | 0.08% | 0.17% | 0.25% | Q1 2021 | Q3 2022 | 2 |
CLRMU | CLARIM ACQUISITION CORP | 2 | 2 | 0.10% | 0.16% | 0.23% | Q1 2021 | Q2 2021 | 2 |
LIANBIO | 2 | 2 | 0.14% | 0.16% | 0.18% | Q4 2021 | Q1 2022 | 2 | |
STEM | STEMCELLS INC | 2 | 2 | 0.08% | 0.16% | 0.25% | Q2 2014 | Q3 2014 | 2 |
MANNKIND CORP | 2 | 2 | 0.16% | 0.16% | 0.16% | Q4 2015 | Q1 2016 | 2 | |
ACRX | ACELRX PHARMACEUTICALS... | 2 | 2 | 0.12% | 0.16% | 0.20% | Q3 2014 | Q4 2014 | 2 |
NLNK | NEWLINK GENETICS CORP | 2 | 2 | 0.14% | 0.16% | 0.17% | Q4 2014 | Q1 2015 | 2 |
HSACU | HEALTH SCIENCES ACQUST... | 2 | 2 | 0.14% | 0.16% | 0.17% | Q2 2019 | Q3 2019 | 2 |
HCAQ | HEALTHCOR CATALIO ACQU... | 2 | 2 | 0.13% | 0.14% | 0.15% | Q1 2021 | Q2 2021 | 2 |
LSAQ | LIFESCI ACQUISITION II... | 2 | 2 | 0.09% | 0.14% | 0.19% | Q4 2020 | Q1 2021 | 2 |
EBIO | ELEVEN BIOTHERAPEUTICS... | 2 | 2 | 0.08% | 0.13% | 0.18% | Q4 2014 | Q1 2015 | 2 |
ZSPH | ZS PHARMA INC | 2 | 2 | 0.10% | 0.12% | 0.15% | Q3 2014 | Q4 2014 | 2 |
VRSK | VERISK ANALYTICS INC | 2 | 2 | 0.11% | 0.12% | 0.14% | Q2 2017 | Q3 2017 | 2 |
ZSAN | ZOSANO PHARMA CORP | 2 | 2 | 0.04% | 0.12% | 0.19% | Q1 2015 | Q2 2015 | 2 |
JUNO | JUNO THERAPEUTICS INC | 2 | 2 | 0.10% | 0.11% | 0.13% | Q4 2014 | Q1 2015 | 2 |
Impax Laboratories Inc | 2 | 2 | 0.08% | 0.11% | 0.14% | Q1 2014 | Q2 2014 | 2 | |
GALT | GALECTIN THERAPEUTICS INC | 2 | 2 | 0.06% | 0.11% | 0.16% | Q1 2015 | Q2 2015 | 2 |
DFPH | DFP HEALTHCARE ACQUISI... | 2 | 2 | 0.08% | 0.10% | 0.12% | Q1 2021 | Q2 2021 | 2 |
TTHI | TRANSITION THERAPEUTIC... | 2 | 2 | 0.01% | 0.10% | 0.19% | Q1 2015 | Q2 2015 | 2 |
CRBP | CORBUS PHARMACEUTICALS... | 2 | 2 | 0.01% | 0.10% | 0.19% | Q2 2020 | Q3 2020 | 2 |
MSTX | MAST THERAPEUTICS INC | 2 | 2 | 0.07% | 0.10% | 0.13% | Q4 2014 | Q1 2015 | 2 |
LFTR | LEFTERIS ACQUISITION CORP | 2 | 2 | 0.08% | 0.08% | 0.09% | Q1 2021 | Q2 2021 | 2 |
APSG | APOLLO STRATEGIC GROWT... | 2 | 2 | 0.05% | 0.08% | 0.11% | Q1 2021 | Q2 2021 | 2 |
Insmed Inc | 2 | 2 | 0.07% | 0.08% | 0.08% | Q1 2014 | Q2 2014 | 2 | |
TWNIU | TAILWIND INTERNATNAL A... | 2 | 2 | 0.03% | 0.07% | 0.11% | Q1 2021 | Q2 2021 | 2 |
LCAP | LIONHEART ACQUISITION ... | 2 | 2 | 0.07% | 0.07% | 0.08% | Q1 2021 | Q2 2021 | 2 |
ETAC | E MERGE TECHNOLOGY ACQ... | 2 | 2 | 0.07% | 0.07% | 0.08% | Q1 2021 | Q2 2021 | 2 |
GMDA | GAMIDA CELL LTD | 2 | 2 | 0.03% | 0.07% | 0.11% | Q4 2020 | Q1 2021 | 2 |
MGTX | MEIRAGTX HOLDINGS PLC | 2 | 2 | 0.06% | 0.07% | 0.08% | Q4 2018 | Q1 2019 | 2 |
IMCR | IMMUNOCORE HLDGS PLC | 1 | 1 | 0.01% | 0.07% | 0.12% | Q1 2021 | Q3 2021 | 2 |
CMLTU | CM LIFE SCIENCES III INC | 2 | 2 | 0.06% | 0.06% | 0.06% | Q2 2021 | Q3 2021 | 2 |
CABO | CABLE ONE INC | 2 | 2 | 0.04% | 0.06% | 0.08% | Q3 2016 | Q4 2016 | 2 |
Auxilium Pharmaceutica... | 2 | 2 | 0.01% | 0.04% | 0.08% | Q1 2014 | Q2 2014 | 2 | |
CNST | CONSTELLATION PHARMCET... | 2 | 2 | 0.03% | 0.04% | 0.05% | Q4 2018 | Q1 2019 | 2 |
ADVM | ADVERUM BIOTECHNOLOGIE... | 2 | 2 | 0.02% | 0.04% | 0.05% | Q3 2018 | Q4 2018 | 2 |
EIDX | EIDOS THERAPEUTICS INC | 2 | 2 | 0.03% | 0.03% | 0.04% | Q2 2018 | Q3 2018 | 2 |
CISN | CISION LTD | 2 | 2 | 0.03% | 0.03% | 0.03% | Q2 2018 | Q3 2018 | 2 |
ADHD | ALCOBRA LTD | 2 | 2 | 0.00% | 0.01% | 0.02% | Q4 2014 | Q1 2015 | 2 |
QQQ | INVESCO QQQ TR | 1 | 1 | 29.76% | 29.76% | 29.76% | Q2 2022 | Q2 2022 | 1 |
INVESCO QQQ TR | 1 | 1 | 13.20% | 13.20% | 13.20% | Q4 2022 | Q4 2022 | 1 | |
JOHNSON & JOHNSON | 1 | 1 | 8.93% | 8.93% | 8.93% | Q4 2013 | Q4 2013 | 1 | |
SPY | SPDR S&P 500 ETF TR | 1 | 1 | 8.05% | 8.05% | 8.05% | Q2 2022 | Q2 2022 | 1 |
MRK | MERCK & CO INC | 1 | 1 | 4.06% | 4.06% | 4.06% | Q2 2021 | Q2 2021 | 1 |
ISHARES TR | 1 | 1 | 3.41% | 3.41% | 3.41% | Q4 2016 | Q4 2016 | 1 | |
PFE | PFIZER INC | 1 | 1 | 3.08% | 3.08% | 3.08% | Q2 2020 | Q2 2020 | 1 |
POWERSHARES QQQ TRUST | 1 | 1 | 2.92% | 2.92% | 2.92% | Q2 2017 | Q2 2017 | 1 | |
LLY | LILLY ELI & CO | 1 | 1 | 2.91% | 2.91% | 2.91% | Q3 2020 | Q3 2020 | 1 |
NVIDIA CORPORATION | 1 | 1 | 2.91% | 2.91% | 2.91% | Q3 2022 | Q3 2022 | 1 | |
MERCK & CO INC NEW | 1 | 1 | 2.79% | 2.79% | 2.79% | Q4 2013 | Q4 2013 | 1 | |
GILD | GILEAD SCIENCES INC | 1 | 1 | 2.68% | 2.68% | 2.68% | Q4 2019 | Q4 2019 | 1 |
CELG | CELGENE CORP | 1 | 1 | 2.58% | 2.58% | 2.58% | Q1 2019 | Q1 2019 | 1 |
JNJ | JOHNSON & JOHNSON | 1 | 1 | 2.52% | 2.52% | 2.52% | Q1 2021 | Q1 2021 | 1 |
GILEAD SCIENCES INC | 1 | 1 | 2.51% | 2.51% | 2.51% | Q4 2013 | Q4 2013 | 1 | |
BMY | BRISTOL-MYERS SQUIBB CO | 1 | 1 | 2.49% | 2.49% | 2.49% | Q3 2021 | Q3 2021 | 1 |
BIOGEN INC | 1 | 1 | 2.46% | 2.46% | 2.46% | Q2 2017 | Q2 2017 | 1 | |
SGEN | SEATTLE GENETICS INC | 1 | 1 | 2.35% | 2.35% | 2.35% | Q4 2019 | Q4 2019 | 1 |
AMD | ADVANCED MICRO DEVICES... | 1 | 1 | 2.13% | 2.13% | 2.13% | Q2 2023 | Q2 2023 | 1 |
XLK | SELECT SECTOR SPDR TR | 1 | 1 | 2.10% | 2.10% | 2.10% | Q2 2021 | Q2 2021 | 1 |
QQQ | POWERSHARES QQQ TRUST | 1 | 1 | 1.98% | 1.98% | 1.98% | Q4 2013 | Q4 2013 | 1 |
TSEM | TOWER SEMICONDUCTOR LTD | 1 | 1 | 1.95% | 1.95% | 1.95% | Q2 2023 | Q2 2023 | 1 |
QQQ | POWERSHARES QQQ TRUST | 1 | 1 | 1.94% | 1.94% | 1.94% | Q1 2018 | Q1 2018 | 1 |
PERRIGO CO PLC | 1 | 1 | 1.81% | 1.81% | 1.81% | Q2 2015 | Q2 2015 | 1 | |
NTR | NUTRIEN LTD | 1 | 1 | 1.80% | 1.80% | 1.80% | Q1 2023 | Q1 2023 | 1 |
UNITY SOFTWARE INC | 1 | 1 | 1.62% | 1.62% | 1.62% | Q3 2022 | Q3 2022 | 1 | |
Merck & Co Inc | 1 | 1 | 1.62% | 1.62% | 1.62% | Q4 2014 | Q4 2014 | 1 | |
BIOGEN INC | 1 | 1 | 1.57% | 1.57% | 1.57% | Q2 2016 | Q2 2016 | 1 | |
NEUROCRINE BIOSCIENCES... | 1 | 1 | 1.57% | 1.57% | 1.57% | Q1 2017 | Q1 2017 | 1 | |
ZIM | ZIM INTEGRATED SHIPPIN... | 1 | 1 | 1.52% | 1.52% | 1.52% | Q1 2022 | Q1 2022 | 1 |
TOWER SEMICONDUCTOR LTD | 1 | 1 | 1.50% | 1.50% | 1.50% | Q4 2022 | Q4 2022 | 1 | |
BIIB | BIOGEN INC | 1 | 1 | 1.30% | 1.30% | 1.30% | Q1 2019 | Q1 2019 | 1 |
ALEXION PHARMACEUTICAL... | 1 | 1 | 1.28% | 1.28% | 1.28% | Q2 2016 | Q2 2016 | 1 | |
TAN | INVESCO EXCH TRADED FD... | 1 | 1 | 1.27% | 1.27% | 1.27% | Q2 2021 | Q2 2021 | 1 |
ACADIA HEALTHCARE COMP... | 1 | 1 | 1.26% | 1.26% | 1.26% | Q2 2016 | Q2 2016 | 1 | |
SEDG | SOLAREDGE TECHNOLOGIES... | 1 | 1 | 1.26% | 1.26% | 1.26% | Q3 2023 | Q3 2023 | 1 |
IFF | INTERNATIONAL FLAVORS&... | 1 | 1 | 1.26% | 1.26% | 1.26% | Q2 2019 | Q2 2019 | 1 |
IWP | ISHARES TR | 1 | 1 | 1.25% | 1.25% | 1.25% | Q3 2020 | Q3 2020 | 1 |
ACHAOGEN INC | 1 | 1 | 1.24% | 1.24% | 1.24% | Q2 2016 | Q2 2016 | 1 | |
GNRC | GENERAC HLDGS INC | 1 | 1 | 1.22% | 1.22% | 1.22% | Q2 2023 | Q2 2023 | 1 |
Bellicum Pharmaceuticals | 1 | 1 | 1.18% | 1.18% | 1.18% | Q4 2014 | Q4 2014 | 1 | |
ALNY | ALNYLAM PHARMACEUTICAL... | 1 | 1 | 1.17% | 1.17% | 1.17% | Q2 2022 | Q2 2022 | 1 |
GLBE | GLOBAL E ONLINE LTD | 1 | 1 | 1.16% | 1.16% | 1.16% | Q3 2022 | Q3 2022 | 1 |
MSFT | MICROSOFT CORP | 1 | 1 | 1.12% | 1.12% | 1.12% | Q2 2023 | Q2 2023 | 1 |
ADBE | ADOBE SYSTEMS INCORPOR... | 1 | 1 | 1.11% | 1.11% | 1.11% | Q3 2022 | Q3 2022 | 1 |
NVS | NOVARTIS AG | 1 | 1 | 1.01% | 1.01% | 1.01% | Q4 2020 | Q4 2020 | 1 |
SWTX | SPRINGWORKS THERAPEUTI... | 1 | 1 | 1.00% | 1.00% | 1.00% | Q1 2022 | Q1 2022 | 1 |
PTLA | PORTOLA PHARMACEUTICAL... | 1 | 1 | 0.99% | 0.99% | 0.99% | Q1 2018 | Q1 2018 | 1 |
XLP | SELECT SECTOR SPDR TR | 1 | 1 | 0.99% | 0.99% | 0.99% | Q1 2020 | Q1 2020 | 1 |
TESARO INC | 1 | 1 | 0.98% | 0.98% | 0.98% | Q2 2016 | Q2 2016 | 1 | |
MNOV | MEDICINOVA INC | 1 | 1 | 0.98% | 0.98% | 0.98% | Q1 2018 | Q1 2018 | 1 |
XLI | SELECT SECTOR SPDR TR | 1 | 1 | 0.98% | 0.98% | 0.98% | Q1 2023 | Q1 2023 | 1 |
SELECT SECTOR SPDR TR | 1 | 1 | 0.98% | 0.98% | 0.98% | Q1 2016 | Q1 2016 | 1 | |
ALT | ALTIMMUNE INC | 1 | 1 | 0.95% | 0.95% | 0.95% | Q3 2021 | Q3 2021 | 1 |
MRK | MERCK & CO. INC | 1 | 1 | 0.94% | 0.94% | 0.94% | Q4 2020 | Q4 2020 | 1 |
LEONARDO DRS INC | 1 | 1 | 0.92% | 0.92% | 0.92% | Q4 2022 | Q4 2022 | 1 | |
CXRX | CONCORDIA HEALTHCARE CORP | 1 | 1 | 0.88% | 0.88% | 0.88% | Q2 2015 | Q2 2015 | 1 |
GENERAC HLDGS INC | 1 | 1 | 0.88% | 0.88% | 0.88% | Q3 2022 | Q3 2022 | 1 | |
SODA | SODASTREAM INTERNATION... | 1 | 1 | 0.87% | 0.87% | 0.87% | Q2 2018 | Q2 2018 | 1 |
ALNYLAM PHARMACEUTICAL... | 1 | 1 | 0.86% | 0.86% | 0.86% | Q2 2016 | Q2 2016 | 1 | |
ASTRAZENECA PLC-SPONS ADR | 1 | 1 | 0.86% | 0.86% | 0.86% | Q3 2014 | Q3 2014 | 1 | |
XLY | SELECT SECTOR SPDR TR | 1 | 1 | 0.84% | 0.84% | 0.84% | Q3 2015 | Q3 2015 | 1 |
XLE | ENERGY SELECT SECTOR S... | 1 | 1 | 0.81% | 0.81% | 0.81% | Q1 2014 | Q1 2014 | 1 |
MWK | MOHAWK GROUP HLDGS INC | 1 | 1 | 0.80% | 0.80% | 0.80% | Q1 2021 | Q1 2021 | 1 |
ASAN | ASANA INC | 1 | 1 | 0.79% | 0.79% | 0.79% | Q4 2021 | Q4 2021 | 1 |
ICLN | ISHARES TR | 1 | 1 | 0.78% | 0.78% | 0.78% | Q1 2021 | Q1 2021 | 1 |
SAGE THERAPEUTICS INC | 1 | 1 | 0.78% | 0.78% | 0.78% | Q2 2016 | Q2 2016 | 1 | |
AN | AutoNation Inc | 1 | 1 | 0.77% | 0.77% | 0.77% | Q2 2014 | Q2 2014 | 1 |
MDAS | MEDA AB-A SHS | 1 | 1 | 0.75% | 0.75% | 0.75% | Q3 2014 | Q3 2014 | 1 |
OPK | OPKO HEALTH INC | 1 | 1 | 0.74% | 0.74% | 0.74% | Q4 2015 | Q4 2015 | 1 |
ISHARES TR | 1 | 1 | 0.68% | 0.68% | 0.68% | Q4 2016 | Q4 2016 | 1 | |
PROMIS NEUROSCIENCES INC | 1 | 1 | 0.67% | 0.67% | 0.67% | Q3 2023 | Q3 2023 | 1 | |
APELLIS PHARMACEUTICAL... | 1 | 1 | 0.67% | 0.67% | 0.67% | Q4 2022 | Q4 2022 | 1 | |
ADSK | AUTODESK INC | 1 | 1 | 0.66% | 0.66% | 0.66% | Q3 2021 | Q3 2021 | 1 |
BYSI | BEYONDSPRING INC | 1 | 1 | 0.65% | 0.65% | 0.65% | Q4 2020 | Q4 2020 | 1 |
B/E Aerospace Inc | 1 | 1 | 0.65% | 0.65% | 0.65% | Q4 2013 | Q4 2013 | 1 | |
CRM | SALESFORCE COM INC | 1 | 1 | 0.64% | 0.64% | 0.64% | Q1 2020 | Q1 2020 | 1 |
FL | Foot Locker Inc | 1 | 1 | 0.64% | 0.64% | 0.64% | Q4 2013 | Q4 2013 | 1 |
TLT | ISHARES TR | 1 | 1 | 0.62% | 0.62% | 0.62% | Q1 2021 | Q1 2021 | 1 |
ARGX | ARGENX SE | 1 | 1 | 0.61% | 0.61% | 0.61% | Q2 2023 | Q2 2023 | 1 |
REPH | RECRO PHARMA INC | 1 | 1 | 0.61% | 0.61% | 0.61% | Q1 2018 | Q1 2018 | 1 |
BOLT | BOLT BIOTHERAPEUTICS INC | 1 | 1 | 0.61% | 0.61% | 0.61% | Q1 2021 | Q1 2021 | 1 |
ITOS | ITEOS THERAPEUTICS INC | 1 | 1 | 0.61% | 0.61% | 0.61% | Q3 2020 | Q3 2020 | 1 |
QCOM | QUALCOMM INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q2 2023 | Q2 2023 | 1 |
AIRBNB INC | 1 | 1 | 0.59% | 0.59% | 0.59% | Q1 2022 | Q1 2022 | 1 | |
SENTINELONE INC | 1 | 1 | 0.58% | 0.58% | 0.58% | Q3 2022 | Q3 2022 | 1 | |
CPRT | Copart Inc | 1 | 1 | 0.58% | 0.58% | 0.58% | Q4 2013 | Q4 2013 | 1 |
APRE | APREA THERAPEUTICS INC | 1 | 1 | 0.58% | 0.58% | 0.58% | Q2 2020 | Q2 2020 | 1 |
GLD | SPDR GOLD TRUST | 1 | 1 | 0.58% | 0.58% | 0.58% | Q3 2017 | Q3 2017 | 1 |
RGDO | Regado Biosciences Inc | 1 | 1 | 0.57% | 0.57% | 0.57% | Q1 2014 | Q1 2014 | 1 |
MWK | MOHAWK GROUP HLDGS INC | 1 | 1 | 0.57% | 0.57% | 0.57% | Q1 2021 | Q1 2021 | 1 |
PCVX | VAXCYTE INC | 1 | 1 | 0.56% | 0.56% | 0.56% | Q1 2023 | Q1 2023 | 1 |
INCY | INCYTE CORP | 1 | 1 | 0.56% | 0.56% | 0.56% | Q4 2017 | Q4 2017 | 1 |
RDHL | Redhill Biopharma Ltd | 1 | 1 | 0.55% | 0.55% | 0.55% | Q1 2014 | Q1 2014 | 1 |
SodaStream Internation... | 1 | 1 | 0.55% | 0.55% | 0.55% | Q4 2013 | Q4 2013 | 1 | |
ARNA | ARENA PHARMACEUTICALS INC | 1 | 1 | 0.55% | 0.55% | 0.55% | Q3 2020 | Q3 2020 | 1 |
AMICUS THERAPEUTICS INC | 1 | 1 | 0.55% | 0.55% | 0.55% | Q1 2016 | Q1 2016 | 1 | |
CYBR | CYBERARK SOFTWARE LTD | 1 | 1 | 0.55% | 0.55% | 0.55% | Q1 2021 | Q1 2021 | 1 |
BioMarin Pharmaceutica... | 1 | 1 | 0.54% | 0.54% | 0.54% | Q1 2014 | Q1 2014 | 1 | |
ZEN | ZENDESK INC | 1 | 1 | 0.53% | 0.53% | 0.53% | Q3 2021 | Q3 2021 | 1 |
GOOGLE INC | 1 | 1 | 0.52% | 0.52% | 0.52% | Q4 2015 | Q4 2015 | 1 | |
DOV | DOVER CORP | 1 | 1 | 0.52% | 0.52% | 0.52% | Q2 2020 | Q2 2020 | 1 |
XENE | XENON PHARMACEUTICALS INC | 1 | 1 | 0.51% | 0.51% | 0.51% | Q3 2023 | Q3 2023 | 1 |
CLDX | CELLDEX THERAPEUTICS I... | 1 | 1 | 0.50% | 0.50% | 0.50% | Q3 2023 | Q3 2023 | 1 |
YHOO | YAHOO INC | 1 | 1 | 0.50% | 0.50% | 0.50% | Q4 2013 | Q4 2013 | 1 |
ESRX | Express Scripts Holdin... | 1 | 1 | 0.49% | 0.49% | 0.49% | Q4 2014 | Q4 2014 | 1 |
ACADIA PHARMACEUTICALS... | 1 | 1 | 0.48% | 0.48% | 0.48% | Q1 2016 | Q1 2016 | 1 | |
RELMADA THERAPEUTICS INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q3 2022 | Q3 2022 | 1 | |
GEMP | GEMPHIRE THERAPEUTICS INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q1 2018 | Q1 2018 | 1 |
KYTH | KYTHERA BIOPHARMACEUTI... | 1 | 1 | 0.47% | 0.47% | 0.47% | Q1 2015 | Q1 2015 | 1 |
AKRO | AKERO THERAPEUTICS INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q3 2019 | Q3 2019 | 1 |
CRWD | CROWDSTRIKE HLDGS INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q3 2023 | Q3 2023 | 1 |
IDRA | IDERA PHARMACEUTICALS INC | 1 | 1 | 0.46% | 0.46% | 0.46% | Q3 2018 | Q3 2018 | 1 |
APPLE INC | 1 | 1 | 0.45% | 0.45% | 0.45% | Q3 2016 | Q3 2016 | 1 | |
CALX | CALIX INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q3 2021 | Q3 2021 | 1 |
ARRAY BIOPHARMA INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q3 2015 | Q3 2015 | 1 | |
AGIO | AGIOS PHARMACEUTICALS INC | 1 | 1 | 0.43% | 0.43% | 0.43% | Q2 2021 | Q2 2021 | 1 |
DICE THERAPEUTICS INC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q3 2022 | Q3 2022 | 1 | |
ACADIA PHARMACEUTICALS... | 1 | 1 | 0.42% | 0.42% | 0.42% | Q4 2013 | Q4 2013 | 1 | |
BIDU | BAIDU INC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q1 2021 | Q1 2021 | 1 |
MLNX | MELLANOX TECHNOLOGIES LTD | 1 | 1 | 0.42% | 0.42% | 0.42% | Q1 2019 | Q1 2019 | 1 |
PCRX | PACIRA PHARMACEUTICALS... | 1 | 1 | 0.41% | 0.41% | 0.41% | Q4 2016 | Q4 2016 | 1 |
CARIBOU BIOSCIENCES INC | 1 | 1 | 0.40% | 0.40% | 0.40% | Q3 2021 | Q3 2021 | 1 | |
NCR | NCR CORPORATION | 1 | 1 | 0.40% | 0.40% | 0.40% | Q1 2014 | Q1 2014 | 1 |
ATER | ATERIAN INC | 1 | 1 | 0.40% | 0.40% | 0.40% | Q2 2021 | Q2 2021 | 1 |
ELOX | ELOXX PHARMACEUTICALS INC | 1 | 1 | 0.39% | 0.39% | 0.39% | Q2 2018 | Q2 2018 | 1 |
FLXN | Flexion Therapeutics Inc | 1 | 1 | 0.39% | 0.39% | 0.39% | Q1 2014 | Q1 2014 | 1 |
PRNB | PRINCIPIA BIOPHARMA INC | 1 | 1 | 0.39% | 0.39% | 0.39% | Q4 2019 | Q4 2019 | 1 |
ONTX | ONCONOVA THERAPEUTICS INC | 1 | 1 | 0.38% | 0.38% | 0.38% | Q4 2013 | Q4 2013 | 1 |
ARIA | ARIAD PHARMACEUTICALS INC | 1 | 1 | 0.38% | 0.38% | 0.38% | Q1 2015 | Q1 2015 | 1 |
CAT | CATERPILLAR INC | 1 | 1 | 0.38% | 0.38% | 0.38% | Q1 2022 | Q1 2022 | 1 |
RADA | RADA ELECTR INDS LTD | 1 | 1 | 0.38% | 0.38% | 0.38% | Q1 2021 | Q1 2021 | 1 |
INTEC PHARMA LTD JERUS... | 1 | 1 | 0.37% | 0.37% | 0.37% | Q2 2019 | Q2 2019 | 1 | |
Medivation Inc | 1 | 1 | 0.37% | 0.37% | 0.37% | Q1 2014 | Q1 2014 | 1 | |
TPTX | TURNING POINT THERAPEU... | 1 | 1 | 0.36% | 0.36% | 0.36% | Q4 2021 | Q4 2021 | 1 |
RTPZ | REINVENT TECHNOLOGY PA... | 1 | 1 | 0.36% | 0.36% | 0.36% | Q1 2021 | Q1 2021 | 1 |
PAG | Penske Automotive Grou... | 1 | 1 | 0.36% | 0.36% | 0.36% | Q2 2014 | Q2 2014 | 1 |
PORTOLA PHARMACEUTICAL... | 1 | 1 | 0.35% | 0.35% | 0.35% | Q1 2016 | Q1 2016 | 1 | |
ATER | ATERIAN INC | 1 | 1 | 0.35% | 0.35% | 0.35% | Q2 2021 | Q2 2021 | 1 |
DYAX CORP | 1 | 1 | 0.35% | 0.35% | 0.35% | Q1 2015 | Q1 2015 | 1 | |
ADXS | ADVAXIS INC | 1 | 1 | 0.35% | 0.35% | 0.35% | Q3 2016 | Q3 2016 | 1 |
VTL | Vital Therapies Inc | 1 | 1 | 0.35% | 0.35% | 0.35% | Q4 2014 | Q4 2014 | 1 |
O REILLY AUTOMOTIVE IN... | 1 | 1 | 0.35% | 0.35% | 0.35% | Q2 2017 | Q2 2017 | 1 | |
TRGT | TARGACEPT INC | 1 | 1 | 0.35% | 0.35% | 0.35% | Q4 2013 | Q4 2013 | 1 |
ESPR | ESPERION THERAPEUTICS ... | 1 | 1 | 0.35% | 0.35% | 0.35% | Q1 2015 | Q1 2015 | 1 |
KRE | SPDR SERIES TRUST | 1 | 1 | 0.35% | 0.35% | 0.35% | Q2 2015 | Q2 2015 | 1 |
ALLO | ALLOGENE THERAPEUTICS INC | 1 | 1 | 0.34% | 0.34% | 0.34% | Q4 2018 | Q4 2018 | 1 |
MREO | MEREO BIOPHARMA GROUP PLC | 1 | 1 | 0.34% | 0.34% | 0.34% | Q1 2021 | Q1 2021 | 1 |
CLOU | GLOBAL X FDS | 1 | 1 | 0.34% | 0.34% | 0.34% | Q1 2021 | Q1 2021 | 1 |
BA | BOEING CO | 1 | 1 | 0.33% | 0.33% | 0.33% | Q4 2016 | Q4 2016 | 1 |
OCUL | OCULAR THERAPEUTIX INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q2 2015 | Q2 2015 | 1 |
DMTX | DIMENSION THERAPEUTICS... | 1 | 1 | 0.33% | 0.33% | 0.33% | Q4 2015 | Q4 2015 | 1 |
SAH | Sonic Automotive Inc | 1 | 1 | 0.33% | 0.33% | 0.33% | Q2 2014 | Q2 2014 | 1 |
FTCH | FARFETCH LTD | 1 | 1 | 0.32% | 0.32% | 0.32% | Q1 2021 | Q1 2021 | 1 |
MRVL | MARVELL TECHNOLOGY GRO... | 1 | 1 | 0.32% | 0.32% | 0.32% | Q2 2018 | Q2 2018 | 1 |
FOREU | FORESIGHT ACQUISITION ... | 1 | 1 | 0.32% | 0.32% | 0.32% | Q1 2021 | Q1 2021 | 1 |
VTAE | VITAE PHARMACEUTICALS INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q4 2015 | Q4 2015 | 1 |
SAVA | CASSAVA SCIENCES INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q1 2020 | Q1 2020 | 1 |
ENPH | ENPHASE ENERGY INC | 1 | 1 | 0.31% | 0.31% | 0.31% | Q2 2020 | Q2 2020 | 1 |
CRBP | CORBUS PHARMACEUTICALS... | 1 | 1 | 0.31% | 0.31% | 0.31% | Q4 2017 | Q4 2017 | 1 |
CTIC | Cell Therapeutics Inc | 1 | 1 | 0.31% | 0.31% | 0.31% | Q1 2014 | Q1 2014 | 1 |
ORLY | O REILLY AUTOMOTIVE IN... | 1 | 1 | 0.31% | 0.31% | 0.31% | Q3 2017 | Q3 2017 | 1 |
CLDX | CELLDEX THERAPEUTICS I... | 1 | 1 | 0.30% | 0.30% | 0.30% | Q1 2015 | Q1 2015 | 1 |
CTIC | Cell Therapeutics Inc | 1 | 1 | 0.30% | 0.30% | 0.30% | Q4 2014 | Q4 2014 | 1 |
XOMA | XOMA CORP DEL | 1 | 1 | 0.30% | 0.30% | 0.30% | Q4 2013 | Q4 2013 | 1 |
AXGT | AXOVANT SCIENCES LTD | 1 | 1 | 0.29% | 0.29% | 0.29% | Q3 2017 | Q3 2017 | 1 |
GOSS | GOSSAMER BIO INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q3 2023 | Q3 2023 | 1 |
ACET | ADICET BIO INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q4 2021 | Q4 2021 | 1 |
CATABASIS PHARMACEUTIC... | 1 | 1 | 0.29% | 0.29% | 0.29% | Q1 2021 | Q1 2021 | 1 | |
ADS | ALLIANCE DATA SYSTEMS ... | 1 | 1 | 0.29% | 0.29% | 0.29% | Q1 2014 | Q1 2014 | 1 |
THRX | THERAVANCE INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q4 2013 | Q4 2013 | 1 |
CRIS | Curis Inc | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2014 | Q1 2014 | 1 |
GALTW | Galectin Therapeutics Inc | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2014 | Q1 2014 | 1 |
PPHM | Peregrine Pharmaceutic... | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2014 | Q1 2014 | 1 |
APLT | APPLIED THERAPEUTICS INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2020 | Q1 2020 | 1 |
NKTR | Nektar Therapeutics | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2014 | Q1 2014 | 1 |
OMER | Omeros Corp | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2014 | Q1 2014 | 1 |
ATRA | ATARA BIOTHERAPEUTICS INC | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2015 | Q1 2015 | 1 |
CKP | Check Point Software T... | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2014 | Q4 2014 | 1 |
ARENA PHARMACEUTICALS INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q3 2014 | Q3 2014 | 1 | |
SLNO | SOLENO THERAPEUTICS INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q2 2020 | Q2 2020 | 1 |
AAVL | AVALANCHE BIOTECHNOLOG... | 1 | 1 | 0.25% | 0.25% | 0.25% | Q1 2015 | Q1 2015 | 1 |
CERU | CERULEAN PHARMA INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q2 2016 | Q2 2016 | 1 |
NITE | NIGHTSTAR THERAPEUTICS... | 1 | 1 | 0.25% | 0.25% | 0.25% | Q3 2017 | Q3 2017 | 1 |
CMPX | COMPASS THERAPEUTICS INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q4 2021 | Q4 2021 | 1 |
PLTK | PLAYTIKA HLDG CORP | 1 | 1 | 0.24% | 0.24% | 0.24% | Q2 2021 | Q2 2021 | 1 |
TNXP | Tonix Pharmaceuticals ... | 1 | 1 | 0.24% | 0.24% | 0.24% | Q1 2014 | Q1 2014 | 1 |
LGVU | LONGVIEW ACQUISITION C... | 1 | 1 | 0.23% | 0.23% | 0.23% | Q1 2021 | Q1 2021 | 1 |
HIPPO HLDGS INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2021 | Q3 2021 | 1 | |
KALA | KALA PHARMACEUTICALS INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q4 2017 | Q4 2017 | 1 |
AKUS | AKOUOS INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q2 2020 | Q2 2020 | 1 |
NXPI | NXP SEMICONDUCTORS N V | 1 | 1 | 0.21% | 0.21% | 0.21% | Q4 2015 | Q4 2015 | 1 |
ISEE | IVERIC BIO INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q2 2022 | Q2 2022 | 1 |
TRMR | TREMOR INTL LTD | 1 | 1 | 0.20% | 0.20% | 0.20% | Q2 2021 | Q2 2021 | 1 |
PHAS | PHASEBIO PHARMACEUTICA... | 1 | 1 | 0.20% | 0.20% | 0.20% | Q1 2021 | Q1 2021 | 1 |
AQST | AQUESTIVE THERAPEUTICS... | 1 | 1 | 0.19% | 0.19% | 0.19% | Q3 2018 | Q3 2018 | 1 |
LOXO | LOXO ONCOLOGY INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q4 2015 | Q4 2015 | 1 |
FREQ | FREQUENCY THERAPEUTICS... | 1 | 1 | 0.18% | 0.18% | 0.18% | Q2 2021 | Q2 2021 | 1 |
FNCH | FINCH THERAPEUTICS GRO... | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2021 | Q1 2021 | 1 |
TIL | INSTIL BIO INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2021 | Q1 2021 | 1 |
THRM | GENTHERM INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2015 | Q1 2015 | 1 |
ALTIMMUNE INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q3 2022 | Q3 2022 | 1 | |
BIOD | Biodel Inc | 1 | 1 | 0.18% | 0.18% | 0.18% | Q1 2014 | Q1 2014 | 1 |
AXGT | AXOVANT SCIENCES LTD | 1 | 1 | 0.18% | 0.18% | 0.18% | Q3 2017 | Q3 2017 | 1 |
OGXI | ONCOGENEX PHARMACEUTIC... | 1 | 1 | 0.17% | 0.17% | 0.17% | Q4 2013 | Q4 2013 | 1 |
COMPUGEN LTD | 1 | 1 | 0.17% | 0.17% | 0.17% | Q1 2014 | Q1 2014 | 1 | |
TWST | TWIST BIOSCIENCE CORP | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2021 | Q2 2021 | 1 |
MEIP | MEI PHARMA INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2020 | Q2 2020 | 1 |
IPSC | CENTURY THERAPEUTICS INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q2 2021 | Q2 2021 | 1 |
CAPA | HIGHCAPE CAP ACQUISITI... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2021 | Q1 2021 | 1 |
IACA | ION ACQUISITION CORP 1... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q4 2020 | Q4 2020 | 1 |
WPF | FOLEY TRASIMENE ACQUIS... | 1 | 1 | 0.15% | 0.15% | 0.15% | Q1 2021 | Q1 2021 | 1 |
FFIV | F5 NETWORKS INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q1 2014 | Q1 2014 | 1 |
MERRIMACK PHARMACEUTIC... | 1 | 1 | 0.15% | 0.15% | 0.15% | Q4 2013 | Q4 2013 | 1 | |
IGLD | INTERNET GOLD-GOLDEN L... | 1 | 1 | 0.15% | 0.15% | 0.15% | Q1 2016 | Q1 2016 | 1 |
PSTX | POSEIDA THERAPEUTICS INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q3 2022 | Q3 2022 | 1 |
SYNTA PHARMACEUTICALS ... | 1 | 1 | 0.15% | 0.15% | 0.15% | Q4 2013 | Q4 2013 | 1 | |
XNPT | XENOPORT INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2013 | Q4 2013 | 1 |
VTGN | VISTAGEN THERAPEUTICS INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2022 | Q2 2022 | 1 |
APTOSE BIOSCIENCES INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2015 | Q2 2015 | 1 | |
EQ | EQUILLIUM INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q1 2021 | Q1 2021 | 1 |
IDRA | IDERA PHARMACEUTICALS INC | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2018 | Q4 2018 | 1 |
SNDX | SYNDAX PHARMACEUTICALS... | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2020 | Q2 2020 | 1 |
ORPN | BIO BLAST PHARMA LTD | 1 | 1 | 0.14% | 0.14% | 0.14% | Q3 2014 | Q3 2014 | 1 |
MOLN | MOLECULAR PARTNERS AG | 1 | 1 | 0.13% | 0.13% | 0.13% | Q3 2021 | Q3 2021 | 1 |
MDWD | MEDIWOUND LTD | 1 | 1 | 0.13% | 0.13% | 0.13% | Q3 2022 | Q3 2022 | 1 |
CORI | Corium International Inc | 1 | 1 | 0.13% | 0.13% | 0.13% | Q2 2014 | Q2 2014 | 1 |
GIGGU | GIGCAPITAL4 INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q1 2021 | Q1 2021 | 1 |
GERN | GERON CORP | 1 | 1 | 0.13% | 0.13% | 0.13% | Q4 2013 | Q4 2013 | 1 |
RXII | RXi Pharmaceuticals Corp | 1 | 1 | 0.13% | 0.13% | 0.13% | Q2 2014 | Q2 2014 | 1 |
NCNA | NUCANA PLC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q3 2017 | Q3 2017 | 1 |
SVAC | STARBOARD VALUE ACQUIS... | 1 | 1 | 0.13% | 0.13% | 0.13% | Q1 2021 | Q1 2021 | 1 |
ERASCA INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2021 | Q3 2021 | 1 | |
KNTE | KINNATE BIOPHARMA INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q2 2022 | Q2 2022 | 1 |
SGNT | SAGENT PHARMACEUTICALS... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2015 | Q1 2015 | 1 |
ARWR | ARROWHEAD PHARMACEUTIC... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2016 | Q3 2016 | 1 |
NSTB | NORTHERN STAR INVSTMNT... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2021 | Q1 2021 | 1 |
TOCA | TOCAGEN INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2019 | Q1 2019 | 1 |
TERN | TERNS PHARMACEUTICALS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2021 | Q1 2021 | 1 |
APOGEE THERAPEUTICS INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2023 | Q3 2023 | 1 | |
KURIU | ALKURI GLOBAL ACQUISIT... | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2021 | Q1 2021 | 1 |
LCAHU | LANDCADIA HOLDINGS IV INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2021 | Q1 2021 | 1 |
FMIVU | FORUM MERGER IV CORP | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2021 | Q1 2021 | 1 |
ACER | ACER THERAPEUTICS INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2019 | Q1 2019 | 1 |
ALCOBRA LTD | 1 | 1 | 0.11% | 0.11% | 0.11% | Q3 2014 | Q3 2014 | 1 | |
PAND | PANDION THERAPEUTICS INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q3 2020 | Q3 2020 | 1 |
Ardelyx Inc | 1 | 1 | 0.10% | 0.10% | 0.10% | Q4 2014 | Q4 2014 | 1 | |
OMIC | SINGULAR GENOMICS SYST... | 1 | 1 | 0.10% | 0.10% | 0.10% | Q2 2021 | Q2 2021 | 1 |
VISTAGEN THERAPEUTICS INC | 1 | 1 | 0.10% | 0.10% | 0.10% | Q3 2023 | Q3 2023 | 1 | |
KRON | KRONOS BIO INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q4 2020 | Q4 2020 | 1 |
VICL | Vical Inc | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2014 | Q1 2014 | 1 |
RAAC | REVOLUTION ACCELERTN A... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2021 | Q1 2021 | 1 |
ACRS | ACLARIS THERAPEUTICS INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q4 2020 | Q4 2020 | 1 |
TCDA | TRICIDA INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2018 | Q2 2018 | 1 |
SPDR S&P 500 ETF Trust | 1 | 1 | 0.08% | 0.08% | 0.08% | Q2 2014 | Q2 2014 | 1 | |
TBLA | TABOOLA.COM LTD | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2022 | Q4 2022 | 1 |
CAPA | HIGHCAPE CAP ACQUISITI... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2021 | Q1 2021 | 1 |
SWBK | SWITCHBACK II CORPORATION | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2021 | Q1 2021 | 1 |
MACQU | MCAP ACQUISITION CORP | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2021 | Q1 2021 | 1 |
VPCBU | VPC IMPACT ACQUISITION... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2021 | Q1 2021 | 1 |
VPCCU | VPC IMPACT ACQU HOLDI ... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2021 | Q1 2021 | 1 |
FCAC | FALCON CAPITAL ACQUISI... | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2021 | Q1 2021 | 1 |
ENFAU | 890 5TH AVE PARTNERS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2021 | Q1 2021 | 1 |
EZCH | EZCHIP SEMICONDUCTOR L... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2015 | Q4 2015 | 1 |
CELC | CELCUITY INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2021 | Q2 2021 | 1 |
CNTB | CONNECT BIOPHARMA HLDG... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2021 | Q1 2021 | 1 |
GLHAU | GLASS HOUSES ACQUISITI... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2021 | Q1 2021 | 1 |
OLMA | OLEMA PHARMACEUTICALS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2020 | Q4 2020 | 1 |
LOKMU | LIVE OAK MOBILITY ACQU... | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2021 | Q1 2021 | 1 |
CRDF | CARDIFF ONCOLOGY INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2020 | Q3 2020 | 1 |
LABP | LANDOS BIOPHARMA INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2021 | Q1 2021 | 1 |
U | UNITY SOFTWARE INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2022 | Q3 2022 | 1 |
OHRP | OHR PHARMACEUTICAL INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2015 | Q1 2015 | 1 |
ALIM | ALIMERA SCIENCES INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2016 | Q3 2016 | 1 |
VKTX | VIKING THERAPEUTICS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2018 | Q3 2018 | 1 |
MGEN | MIRAGEN THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2020 | Q4 2020 | 1 |
TCRR | TCR2 THERAPEUTICS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q2 2020 | Q2 2020 | 1 |
CYCN | CYCLERION THERAPEUTICS... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2020 | Q1 2020 | 1 |
PTX | PERNIX THERAPEUTICS HL... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2013 | Q4 2013 | 1 |
SPRQ | SPARTAN ACQUISITION CO... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 |
VTIQU | VECTOIQ ACQUISITION CO... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 |
CALT | CALLIDITAS THERAPEUTIC... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2023 | Q3 2023 | 1 |
UPWK | UPWORK INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2021 | Q3 2021 | 1 |
EJFAU | EJF ACQUISITION CORP | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 |
AGGRU | AGILE GROWTH CORP | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 |
SCAQU | STRATIM CLOUD ACQUISIT... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 |
ZWRKU | Z-WORK ACQUISITION CORP | 1 | 1 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q1 2021 | 1 |
SPPI | SPECTRUM PHARMACEUTICA... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2015 | Q1 2015 | 1 |
TUFN | TUFIN SOFTWARE TECHNOL... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2019 | Q3 2019 | 1 |
Corcept Therapeutics Inc | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2014 | Q1 2014 | 1 | |
HSIC | SCHEIN HENRY INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2016 | Q3 2016 | 1 |
GLIBA | GCI LIBERTY INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2018 | Q1 2018 | 1 |
BMYRT | BRISTOL-MYERS SQUIBB CO | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2020 | Q1 2020 | 1 |
MDHU | MDH ACQUISITION CORP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2021 | Q1 2021 | 1 |
CMLF | CM LIFE SCIENCES INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2021 | Q1 2021 | 1 |
NRACU | NOBLE ROCK ACQUISITION... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2021 | Q1 2021 | 1 |
Energy Select Sector S... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q4 2014 | Q4 2014 | 1 | |
TISA | TOP Image Systems Ltd | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2014 | Q2 2014 | 1 |
FTEVU | FINTECH EVOLUTION ACQU... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2021 | Q1 2021 | 1 |
MIST | MILESTONE PHARMACEUTIC... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2020 | Q1 2020 | 1 |
89BIO INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2022 | Q4 2022 | 1 | |
MCUR | MACROCURE LTD | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2014 | Q3 2014 | 1 |
AUXL | AUXILIUM PHARMACEUTICA... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2014 | Q3 2014 | 1 |
Cytokinetics Inc | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2014 | Q1 2014 | 1 | |
Vertex Pharmaceuticals... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2014 | Q2 2014 | 1 | |
CDTX | CIDARA THERAPEUTICS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2017 | Q4 2017 | 1 |
AIMT | AIMMUNE THERAPEUTICS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2015 | Q3 2015 | 1 |
Download |
The securities at the top of the list , including TEVA PHARMACEUTICAL-SP ADR, MERCK & CO INC NEW, and NICE Systems Ltd, are the highest-conviction holdings of SPHERA FUNDS MANAGEMENT LTD..
The conviction is calculated by counting the number of quarters a security has been reported by SPHERA FUNDS MANAGEMENT LTD.. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that SPHERA FUNDS MANAGEMENT LTD. owns currently or has owned in the past.